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Kaice Arminda LaFavers 
A FORWARD GENETIC APPROACH TO IDENTIFYING NOVEL 
CALCIUM REGULATORS IN TOXOPLASMA GONDII 
 
Toxoplasma gondii is an obligate intracellular eukaryotic pathogen that causes 
severe neurologic disease in immunocompromised adults and congenitally 
infected neonates. Events critical to the propagation of T. gondii, such as invasion 
and egress, are regulated by calcium-dependent signaling. In order to identify 
unique components of the parasite’s calcium signaling networks, members of the 
Arrizabalaga laboratory have used a forward genetics approach to isolate mutants 
with altered sensitivity to the calcium ionophore A23187. Exposing extracellular 
parasites to A23187 induces protein secretion, motility and cytoskeletal 
rearrangements and prolonged treatment causes exhaustion of factors required 
for invasion, which results in what is referred to as ionophore induced death 
(iiDeath). Mutants capable of surviving this treatment were isolated from a 
chemically mutagenized population. Whole genome sequencing of one such 
mutant, MBD2.1, identified a nonsense mutation in a protein of unknown function 
(TGGT1_069070, ToxoDBv7.2) Complementation of MBD 2.1 with a wild-type 
copy of TGGT1_069070 restored sensitivity to iiDeath treatment. Endogenous 
tagging of this locus revealed that the encoded protein is secreted from a unique 
parasite secretory organelle known as the dense granule into the parasitophorous 
vacuole, leading to its designation as TgGRA41. Complete knockout of TgGRA41 
recapitulates the resistance to iiDeath observed in MBD2.1 but also exhibits a 
 v 
dramatic decrease in propagation in tissue culture not seen in the original mutant. 
The knockout shows defects in multiple steps of the lytic including compromised 
invasion efficiency and premature egress of parasites from host cells. Cytosolic 
calcium measurements of extracellular parasites show enhanced uptake of 
calcium in the knockout strain as compared to parental and complemented, 
suggesting that the loss of TgGra41 results in calcium dysregulation. Together, 
these results provide a novel insight into the role that the parasitophorous vacuole 
of T. gondii plays in calcium homeostasis and calcium-dependent signaling 
processes. 
 
Gustavo Arrizabalaga, Ph.D., Chair 
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Chapter 1 : Introduction 
Specific Aims 
Toxoplasma gondii is an obligate intracellular eukaryotic pathogen 
responsible for potentially fatal infections in immunocompromised individuals and 
neonates. Current treatments for clinical Toxoplasmosis exhibit high rates of 
toxicity and cannot clear the chronic form of the disease (Luft and Remington 
1992). The identification and characterization of processes and proteins that are 
both unique to the parasite and crucial for its survival is key for the discovery of 
new drug targets. In this context, calcium-dependent signaling represents an ideal 
target since it controls key aspects of the parasite’s life cycle, and depends on 
many proteins that are unique to the parasite and absent in the mammalian host 
(Arrizabalaga and Boothroyd 2004, Nagamune 2009, Lourido and Moreno 2015). 
In order to identify novel calcium signaling factors, members of the Arrizabalaga 
laboratory have used a forward genetic approach to isolate mutants able to resist 
prolonged extracellular exposure to the calcium ionophore A23187. Ionophore 
treatment of extracellular parasites induces excessive secretion of invasion-related 
proteins, rendering parasites non-invasive, a phenomenon termed ionophore 
induced death (iiDeath). Members of the Arrizabalaga and Boothroyd laboratories 
were able to isolate a mutant, MBD 2.1, which remains invasive after this 
treatment. This mutant is also hypersensitive to the chelation of intraparasitic 
calcium by BAPTA-AM, suggesting that it may have disregulated calcium 
homeostasis (Black, Arrizabalaga et al. 2000). Whole genome sequencing of the 
mutant and its parental strain identified multiple single nucleotide variants, two of 
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which lead to changes in the primary sequence of encoded proteins. Given that 
the common thread between the phenotype by which the MBD 2.1 mutant was 
isolated (iiDeath resistance) and this sensitivity to the calcium chelator BAPTA-AM 
is calcium, I hypothesize that identifying the causative mutation for iiDeath 
resistance in MBD2.1 will allow us to identify a novel protein regulator of calcium 
homeostasis within the parasite. I will test this hypothesis through the following 
aims: 
Specific Aim 1: Determine the causative mutation in mutant MBD2.1 
and characterize the protein responsible for resistance to iiDeath. Chemical 
mutagenesis and selection of the RH∆hxgprt strain led to the isolation of MBD2.1, 
which exhibits resistance to iiDeath. Whole genome sequencing of the mutant and 
parental strains identified candidate single nucleotide variants that could be 
responsible for this phenotype. To identify the causative mutation, I will attempt to 
complement the iiDeath- phenotype by transfecting in wild-type copies of the 
mutated genes. Upon identification of the causative mutation, I will endogenously 
tag the responsible gene to determine the localization of the encoded protein. 
Additionally, I will generate a complete knockout of the responsible gene to verify 
that this recapitulates the resistance to iiDeath and to further characterize any 
phenotypes associated with the loss of this protein. 
Specific Aim 2: Determine the mechanistic role of the iiDeath protein. 
Based on the resistance to iiDeath and hypersensitivity to BAPTA-AM seen in 
mutant MBD2.1, it is likely that the iiDeath protein impacts calcium homeostasis 
within the parasite. With this in mind, I will utilize the iiDeath protein knockout 
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generated in Aim 1 to test calcium levels in the parasite cytosol under normal and 
stimulated conditions. I will also generate recombinant iiDeath protein to 
investigate whether this protein is capable of binding calcium. In parallel I will 
explore the function of the iiDeath protein in an unbiased approach by identifying 
interacting proteins. I will also examine the morphology of the iiDeath protein 
knockout to look for any structural defects. 
Specific Aim 3: Determine the impact of the iiDeath protein on the 
establishment and progression of infection in vivo. The forward genetic 
approach used to generate the MBD2.1 mutant was conducted in a highly virulent 
strain that does not establish a chronic infection and cannot be used to determine 
the full spectrum of the iiDeath protein’s role during infection. Accordingly, I will 
generate a knockout of the iiDeath protein in a strain suitable for in vivo and 
developmental studies. This will allow us to test the role of this novel protein in the 
generation of chronic stage cysts in tissue culture and in vivo and development of 
acute and chronic infection in vivo. 
Clinical Significance 
T. gondii is an obligate intracellular parasite of the phylum Apicomplexa that 
causes widespread infection among many vertebrates, including humans (San 
Miguel, Gutierrez-Exposito et al. 2016). It is estimated that approximately a third 
of the world’s human population is infected with this opportunistic pathogen. 
Humans become infected congenitally or by ingestion of either environmental 
oocysts, which are shed in the feces of cats, or tissue cysts, found in the 
undercooked meat of infected animals (Pappas, Roussos et al. 2009).  
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Though immunocompetent individuals will not generally experience 
symptoms during infection, T. gondii can be particularly devastating in 
immunocompromised individuals and those infected congenitally (Mazzillo, 
Shapiro et al. 2013, Oray, Ozdal et al. 2015). During the acute stage of the 
infection, T. gondii propagates through repeated lytic cycles of host cell invasion, 
growth and egress as a rapidly dividing form known as the tachyzoite, resulting in 
significant host cell death (Black and Boothroyd 2000). The tissue damage elicited 
by parasite propagation is normally limited by an immune response that relies on 
both CD4+ and CD8+ T cells, which induces conversion to the cyst-forming 
bradyzoite stage and the establishment of a chronic infection (Landrith, Harris et 
al. 2015).  
In immunocompromised individuals and lymphoma patients, new infections 
or rupture of pre-existing tissue cysts can lead to toxoplasmic encephalitis (Luft 
and Remington 1992, Israelski and Remington 1993, Slavin, Meyers et al. 1994).  
Toxoplasmic encephalitis can be a difficult diagnosis to make; the most common 
associated symptoms are nonspecific headache, confusion and fever. However, 
this can progress to coma and death if left untreated and in a small minority of 
treated patients as well (Porter and Sande 1992). Neuropathological analysis of 
toxoplasmic encephalitis by magnetic resonance imaging (MRI) shows visible 
lesions that are the result of tissue damage caused by lysis of host cells by the 
parasite (Neuen-Jacob, Figge et al. 1993). Current anti-retroviral treatments 
directed at the human immunodeficiency virus (HIV) have reduced the overall 
incidence and mortality of toxoplasmic encephalitis in the HIV-infected population, 
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one of the largest population groups at risk for developing this severe complication. 
However, toxoplasmic encephalitis remains an important cause of morbidity and 
mortality in the subset of this population whose HIV infection remains undetected 
for prolonged periods of time, referred to as late presenters (Martin-Iguacel, 
Ahlstrom et al. 2017). Toxoplasmic encephalitis continues to remain a concern for 
other immunosuppressed patients, such as those who have received organ 
transplants (Greenway, Sacco et al. 2017). Another important 
immunocompromised population includes those individuals who are infected 
congenitally, who may experience severe neurological problems or even death as 
a result of T. gondii infection of the central nervous system, given the immature 
nature of the fetal immune system (Wilson, Remington et al. 1980). 
In all patient populations, T. gondii infection can result in the development 
of eye infections to the retina (ocular toxoplasmosis) that can cause scarring, 
blurred vision or even loss of sight. Though it was originally thought that the 
majority of ocular toxoplasmosis cases were acquired congenitally, recent studies 
show that many cases are acquired postnatally (Gilbert and Stanford 2000). 
Current evidence suggests that both types of exposure lead to infection of the eye 
tissue from parasites circulating in the blood rather than from the nervous system 
(Park 2012). Despite this, they have very different clinical presentations if left 
untreated, with postnatally acquired cases often resulting in a focal necrotizing 
retinitis that may not dramatically impair vision (Cochereau-Massin, LeHoang et al. 
1992), and congenitally acquired infections causing widespread lesions throughout 
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the retina, which often results in damage to the macula and vision loss (Mets, 
Holfels et al. 1997). 
T. gondii Life Cycle 
The T. gondii life cycle is a complex one, utilizing both a definitive host in 
which sexual reproduction may occur and intermediate hosts where the parasite 
can only reproduce asexually (Figure 1.1, below). The definitive host of T. gondii 
is the cat and the feline intestine is capable of supporting both asexual and sexual 
reproduction of the parasite. Initial replication within the feline gut occurs asexually 
before parasites switch to production of micro- and macrogametes in response to 
as yet uncharacterized signals (Weiss and Kim 2014). Though these gametes are 
capable of generating cross-fertilized parasites (Pfefferkorn and Pfefferkorn 1980), 
the actual fertilization event has not been observed. The resulting oocysts 
produced by the sexual stages are shed for 1-2 weeks in the feces of the cat and 
are capable of initiating an acute infection in animals that consume them (Frenkel, 
Dubey et al. 1970). Though domesticated cats play a key role in disease 
transmission among humans, all tested felids are capable of producing oocysts. T. 
gondii  has  been able to establish infections in a large variety of vertebrates 
worldwide in any area where infected felines are present (Jewell, Frenkel et al. 
1972). 
The oocyst is the only stage in the life cycle of T. gondii capable of 
undergoing development outside of a host cell (extracellular growth). After the 
oocyst is shed in the feces of the cat its contents differentiate from a single 
cytoplasmic mass known as the sporoblast to two sporocysts. Each sporocyst 
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contains four sporozoites capable of invading host cells and generating an acute 
infection in the intermediate host (Birch-Andersen, Ferguson et al. 1976). The 
oocysts are highly stable in the environment and can last from months to years, 
depending on the moisture content and temperature of the soil; they are 
particularly stable under cool, damp conditions (Lelu, Villena et al. 2012). Upon 
ingestion, the sporozoites will excyst from the oocyst and are able to infect host 
cells. Though the process of excystation has not been monitored in vivo, in vitro 
studies show that a fluid containing trypsin and bile salts can stimulate this 
process, suggesting that the trigger for excystation is the host digestive tract 
(Speer, Clark et al. 1998). Within 1-2 lytic cycles of the sporozoite invading the 
host, the sporozoite will convert to the rapidly replicating form of the parasite known 
as the tachyzoite, which characterizes the acute infection in the intermediate host 
(Speer, Tilley et al. 1995).  
The tachyzoite life stage is responsible for the tissue damage, rapid 
dissemination to distant tissues and symptomology seen in the acute stage of T. 
gondii infection. Repeated cycles of host cell invasion, parasite replication and 
egress by the tachyzoite result in the lysis and death of the host cell. In 
immunocompetent individuals, the acute infection is rapidly cleared by the immune 
system as described previously. The tachyzoite form of the parasite is not often 
responsible for transmission of infections to a new host, except in the case of 
congenital transmission or more rarely as a result of laboratory accidents or blood 
transfusions (Parker and Holliman 1992, Karimi, Mardan et al. 2014). A mother 
who is infected for the first time during pregnancy can transmit the disease to her 
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fetus as the tachyzoite can cross the placental barrier (Jones, Lopez et al. 2003). 
The rate of fetal seroconversion and health outcomes vary over the course of 
pregnancy and are inversely correlated with one another, with infection in the first 
trimester relatively rare, but associated with severe birth defects and potential 
miscarriage, and infection in the third trimester much more likely but with limited 
impact on the fetus (Montoya and Liesenfeld 2004). 
 
Figure 1.1 Life cycle of T. gondii 
The complete life cycle of T. gondii occurs in felids and their prey. 
Highly infectious oocysts are shed in the feces of the felid and are 
ingested by prey. Following acute infection, the parasite will form 
tissue cysts, which are highly infectious to felids. Humans can be 
infected by exposure to occysts and tissue cysts, congenitally, or 
via organ transplant/blood transfusion. 
The tachyzoite converts to a slower growing, tissue cyst-forming stage 
known as the bradyzoite in response to immune system pressure in the 
intermediate host (Weiss and Kim 2000). The tissue cyst formed by the bradyzoite 
is protected by a cyst wall, which is dependent on extensive glycosylation of its 
components for tissue cyst persistence in a mouse model (Caffaro, Koshy et al. 
2013). During the initial stages of tissue cyst formation and bradyzoite maturation, 
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the parasites continue to replicate slowly, but this replication becomes relatively 
rare in mature cysts (Ferguson and Hutchison 1987). The bradyzoite is the final 
life cycle stage observed in the immunocompetent intermediate host, but it is a 
crucial one for propagation to a new host. In order to complete its life cycle, the 
parasite must return to its definitive host, and evidence suggests that the most 
infectious form of T. gondii for cats is the bradyzoite (Dubey 2006). Bradyzoite 
cysts are also infectious to other intermediate hosts and cysts in raw or 
undercooked meat are an important source of infection for humans (Tenter, 
Heckeroth et al. 2000).  
T. gondii Lytic Cycle 
The lytic cycle of the T. gondii tachyzoite (Figure 1.2, below), which is at the 
center of its propagation and pathogenesis, begins with the active attachment and 
invasion of parasites into host cells, a process that is dependent on the secretion 
of proteins from specialized secretory organelles known as the micronemes and 
rhoptries (Carruthers and Sibley 1997). Invasion initiates the formation of a 
parasitophorous vacuole (PV) through the invagination of the host cell membrane 
(Suss-Toby, Zimmerberg et al. 1996). Following parasite growth within the PV, the 
cycle is reinitiated after the parasites actively egress the host cell and invade 
neighboring host cells. In recent years, many of the key molecular players in the 
lytic cycle have been identified. Unique proteins with adhesive properties are first 
released from the micronemes, where they interact with both the plasma 
membrane of the parasite and the host cell surface (Carruthers and Sibley 1997, 
Garcia-Reguet, Lebrun et al. 2000). Active invasion of the host cell is dependent 
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on a micronemal protein, Apical Membrane Antigen 1 (AMA1), along with proteins 
secreted from the rhoptries, rhoptry neck proteins 2, 4, 5 and 8 (RONs 2,4,5,8). 
These proteins assemble to form a moving junction, where RONs 2, 4,5, and 8 are 
associated with the host cell plasma membrane and AMA1 is associated with the 
parasite plasma membrane. A high affinity interaction between AMA1 and RON2 
brings the parasite into close contact with the host cell plasma membrane and is 
necessary for rapid invasion of the host cell as the parasite moves through the 
moving junction into the host cytosol (Alexander, Mital et al. 2005, Lebrun, Michelin 
et al. 2005, Alexander, Arastu-Kapur et al. 2006, Beck, Chen et al. 2014). Invading 
parasites do not cross the host cell plasma membrane and instead cause it to 
invaginate; the parasite then uses this membrane to form the membrane of the  
 
Figure 1.2 Lytic Cycle of T. gondii 
The lytic cycle begins with the active attachment of a parasite 
(shown in black) to a new host cell (outlined in grey). The 
parasite then actively invades the host cell and invaginates the 
host cell membrane to create the parasitophorous vacuole. It 
then replicates within this vacuole before actively egressing 
from the host cell and moving to a nearby cell to begin the cycle 
again. 
parasitophorous vacuole. During invasion, this membrane is stripped of the 
majority of host cell transmembrane proteins, though GPI-anchored host proteins 
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have been found in the resulting vacuole membrane (Mordue, Desai et al. 1999). 
Once the parasite is completely internalized, proteins secreted from the rhoptries 
and a third secretory organelle, the dense granule, traffic to both the newly formed 
vacuole and the host cell to create a niche for parasite replication (Carruthers and 
Sibley 1997).  
Once inside the host cell, tachyzoites replicate by a process known as 
endodyogeny, in which a single mother parasite replicates its entire genome and 
organelles before dividing into two daughter parasites. This process results in 
ageometric expansion in parasite number, with doublings occurring every 5-9 
hours in vitro, depending on the strain (Radke, Striepen et al. 2001). The number 
of doublings that a parasite undergoes before leaving a single host cell depends 
on a number of factors, including the size and type of host cell, the average number 
of parasites per host cell (multiplicity of infection or MOI) and the presence of 
signaling molecules (Nagamune, Hicks et al. 2008). When grown in human 
foreskin fibroblasts (HFFs) in vitro, parasites typically complete 5-7 division cycles 
over the course of 2-3 days before egressing (Black and Boothroyd 2000). In vivo, 
tachyzoites are found replicating within immune cells shortly after the initiation of 
an acute infection, where they typically only divide a few times before egressing 
(Tomita, Yamada et al. 2009). Thus, it is possible that the kinetics of parasite 
propagation in the mouse are quite different from what is seen in tissue culture.  
In both natural and induced egress observed in vitro, the parasites actively 
leave the cell in a coordinated manner that requires activation of the parasite 
motility machinery. The parasite relies on an actin/myosin-based motility system 
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that is anchored just beneath the parasite membrane in a series of flattened sacs 
known as the inner membrane complex (IMC). This complex, known as the 
glideosome, consists of multiple IMC-bound proteins that act as an anchor for a 
myosin motor protein which interacts with filamentous actin to generate a motive 
force (Frenal, Polonais et al. 2010). Recent work from our lab demonstrates that 
the activation of a calcium-dependent protein kinase (CDPK3) following an 
increase in calcium levels within the parasite leads to the phosphorylation of the 
glideosome’s myosin motor MYOA. This phosphorylation is required for maximal 
activation of MYOA, which is required for efficient and rapid host cell egress (Gaji, 
Johnson et al. 2015). Once this motility machinery is engaged, the parasites will 
leave the cell and travel to a neighboring cell where they can reinitiate the process 
of host cell attachment and invasion (Black and Boothroyd 2000). 
Cell Biology of T. gondii 
DNA-containing Organelles 
T. gondii houses the majority of its genomic material in a large, centrally 
located nucleus (Figure 1.3, below). The haploid genome (approximately 69 Mbp) 
is spread among 14 chromosomes and encodes more than 8,000 genes (Lau, Lee 
et al. 2016). Curated versions of the T. gondii genome are maintained online at 
ToxoDB.org. T. gondii has two additional DNA-containing organelles, the 
mitochondrion, found in all eukaryotes, and a plastid-like organelle known as the 
apicoplast (Figure 1.3, below). As has been accepted to be the case for eukaryotic 
mitochondria, the apicoplast is also thought to be the result of engulfment of an 
endosymbiont (Gray 2017). Though the genome of the parasite’s single 
 13 
mitochondrion remains unresolved, it has been shown that the parasite 
mitochondrion is functional (i.e. generates a membrane potential through the 
activity of the electron transport chain) in both intra and extracellular parasites 
(Melo, Attias et al. 2000). Recent work has demonstrated that the parasite 
mitochondrion imports proteins using components of the TOM complex, which has 
been well characterized in model eukaryotes (Fukasawa, Oda et al. 2017). 
Conditional knockdown of proteins in this complex block parasite replication in 
vitro, suggesting that mitochondrial function is absolutely required for the 
tachyzoite stage of the life cycle (van Dooren, Yeoh et al. 2016). The apicoplast is 
a plastid-like organelle that is likely the result of a secondary endosymbiotic event 
wherein the ancestor of the parasite engulfed a red algal photosynthetic eukaryote 
to establish the chromalveolate lineage (Gould, Waller et al. 2008). Though many 
chromalveolates retain photosynthetic capabilities within their plastids, members 
of the apicomplexan phylum that have evolved as parasitic organisms have lost 
this function (McFadden and Yeh 2017). In fact, it appears that the only reason 
that the apicoplast is essential for T. gondii growth is due to the production of 
precursors of the isoprenoid pathway that takes place inside this organelle (Nair, 
Brooks et al. 2011). 
Plasma Membrane and Associated Organelles 
Just underneath the plasma membrane of T. gondii and all other alveolates 
(apicomplexans, dinoflagelletas and ciliates) is a series of flattened sacs called 
alveoli (Ruggiero, Gordon et al. 2015). In T. gondii, these sacs come together to 
form the inner membrane complex (IMC), which covers the entirety of the plasma 
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membrane with the notable exception of the apical tip (Vivier and Petitprez 1969). 
The sacs are restricted to the area beneath a structure called the apical polar ring, 
leaving the apical tip of the parasite free, perhaps to facilitate secretion (Tran, de 
Leon et al. 2010). In addition to acting as a starting point for the IMC, the apical 
polar ring also acts as an anchor for 22 subpellicular microtubules that extend out 
from the ring in a spiral (Russell and Burns 1984). The microtubules line up with 
the IMC sacs to form a structure that helps the parasite to maintain its typical 
banana shape (Nichols and Chiappino 1987).  
In addition to its role in maintaining parasite morphology, the IMC also 
houses the parasite motility machinery, called the glideosome (Opitz and Soldati 
2002). Many of the proteins associated with the glideosome (Glideosome 
Associated Proteins or GAPs) are anchored in the membranes of the IMC through 
transmembrane domains (Bullen, Tonkin et al. 2009). They anchor the 
actin/myosin motor complex that propels the parasite forward in its typical gliding 
motion (Frenal, Polonais et al. 2010). Evidence also suggests that the IMC is 
capable of storing calcium (Bonhomme, Pingret et al. 1993), which would make it 
a convenient potential store for the calcium that is required for activation of 
glideosome components by calcium-dependent protein kinases (Gaji, Johnson et 
al. 2015).  
The apical tip of the parasite contains a unique structure known as the 
conoid, which is composed of microtubules arranged in a specific structure (Hu, 
Roos et al. 2002). Normally the conoid is retracted within the apical polar ring that 
demarcates the beginning of the IMC, but is extended during invasion (Del 
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Carmen, Mondragon et al. 2009) and in response to artificial induction of calcium 
fluxes within the parasite (Mondragon and Frixione 1996). Though the exact 
function of the conoid is unknown, it is plausible that this structure plays a key role 
in parasite attachment and/or invasion. In fact, supporting this notion, non-
apicomplexan alveolates with an incomplete conoid and apical secretory 
organelles use these structures to either partially or fully invade other free-living 
protozoa to obtain nutrients required for growth (Beis, Andre et al. 2002, 
Brugerolle, Bricheux et al. 2002, Leander, Kuvardina et al. 2003). 
Secretory Organelles 
The apical end of the parasite is also home to two unique secretory 
organelles, the small oval micronemes and the long club-shaped rhoptries (Figure 
1.3, below), whose contents are released at specific times during the lytic cycle 
(Carruthers and Sibley 1997) and are essential for attachment, invasion, egress 
and modulation of the host immune system (Huynh, Rabenau et al. 2003, Huynh 
and Carruthers 2006, El Hajj, Lebrun et al. 2007, Fentress and Sibley 2011, Tyler 
and Boothroyd 2011, Niedelman, Gold et al. 2012). The micronemes release 
multiple adhesive proteins (MICs) responsible for forming the initial attachment of 
the parasite to a new host cell prior to invasion (Carruthers, Giddings et al. 1999, 
Cerede, Dubremetz et al. 2005). A complex known as the moving junction is then 
formed from micronemal and rhoptry-derived proteins. It is through this structure 
that the parasite will travel through to invade the host cell (Alexander, Mital et al. 
2005, Straub, Peng et al. 2011, Beck, Chen et al. 2014). This complex and its role 
in invasion are described in more detail in the T. gondii lytic cycle section. The 
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rhoptries will continue to release their contents (ROPs for proteins secreted from 
the body of the rhoptry, RONs for those secreted from the rhoptry neck) into the 
newly formed parasitophorous vacuole and even into the host cell to modulate host 
cell immune responses (Boothroyd and Dubremetz 2008).  
The dense granules are an additional secretory organelle that are found 
throughout the parasite (Figure 1.3, below) which release their contents 
constitutively throughout the parasite lytic cyle (Chaturvedi, Qi et al. 1999). When 
dense granule proteins are secreted from an intracellular parasite, they may be 
trafficked to one or more of four locations: the lumen of the parasitophorous 
vacuole, the parasitophorous vacuole membrane (PVM), the membranes of the 
tubulovesicular network (TVN), found throughout the vacuolar space or beyond the 
vacuole into the host cell (Sibley, Niesman et al. 1995, Lecordier, Mercier et al. 
1999, Rome, Beck et al. 2008, Bougdour, Durandau et al. 2013). The majority of 
dense granule proteins share no sequence homology with characterized proteins 
from other organisms and homologs are often restricted to closely related species 
(i.e. those in the subfamily Toxoplamatinae), and are missing from other well-
studied apicomplexans, such as Plasmodium species, suggesting that this group 
of proteins has evolved to specifically support T. gondii’s lifestyle (Mercier, 
Adjogble et al. 2005).  The NTPases that are secreted from the dense granules 
into the parasitophorous vacuole are one notable exception to this rule with a 
conserved NTPase domain that has been shown to be enzymatically active (Asai, 
O'Sullivan et al. 1983, Bermudes, Peck et al. 1994, Sibley, Niesman et al. 1994). 
Though most dense granule proteins studied thus far are dispensable for in vitro 
 17 
growth, they have been shown to play key roles in in vivo virulence, vacuole 
structure, host cell immune response and antigen presentation (Mercier, Cesbron-
Delauw et al. 1998, Mercier, Howe et al. 1998, Travier, Mondragon et al. 2008). 
Other GRA proteins that are trafficked to the host cell have been shown to play 
important roles in strain-specific activation of the NFkB pathway (Rosowski, Lu et 
al. 2011), regulation of the p53 tumor suppressor pathway to enhance parasite 
virulence (Bougdour, Durandau et al. 2013), and regulation of the p38a MAPK 
pathway (Braun, Brenier-Pinchart et al. 2013).  
Parasitophorous Vacuole 
The parasite creates a parasitophorous vacuole during invasion by 
invaginating the host cell plasma membrane and stripping it of the majority of its 
proteins, rendering it non-fusogenic with the host cell endolysosomal system 
(Mordue, Hakansson et al. 1999). Parasite secreted proteins, whose identities 
were only recently identified, are trafficked into the vacuole membrane where they 
form a pore which allows molecules less than 1300 daltons to pass from the host 
cell cytosol to the parasitophorous vacuole lumen, allowing the parasite access to 
host cell nutrients (Schwab, Beckers et al. 1994, Gold, Kaplan et al. 2015). Also 
localized to the vacuole membrane are multiple rhoptry-derived kinases that are 
key determinants of virulence in a mouse model due to their ability to 
phosphorylate and inactivate the immunity-related GTPases used by mice to 
control intracellular pathogens (Etheridge, Alaganan et al. 2014). Though the 
export of multiple parasite proteins into the host cell suggests that the PVM must 
also contain a complex capable of transporting proteins across this membrane, the 
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molecular components of such a complex have yet to be identified. An attempt to 
identify T. gondii homologues to the components of the PV protein export complex 
of its apicomplexan relative, Plasmodium, identified the nutrient pore described 
above, suggesting that mechanisms for protein export across the PV membrane 
within these two parasites evolved independently (Gold, Kaplan et al. 2015). 
Within the vacuole is found a network of membranous tubules known as the 
tubulovesicular network (TVN). The network is formed following the secretion of 
multi-lamellar vesicles from the basal end of the parasite shortly after host cell 
infection. These vesicles then fuse together to form the long membranous tubules 
of the TVN, which are 40-60 nm in diameter and may extend up to 1 μM long. 
Electron microscopy analysis of the TVN shows that some, but not all of the tubules 
are continuous with the PVM (Sibley, Niesman et al. 1995). Multiple dense granule 
proteins are required for the formation of the TVN, and genetic disruption of these 
proteins leads to the accumulation of membranous material or partially formed 
tubules within the vacuole. Though vacuoles without a TVN are capable of growth 
in vitro, they show dramatically decreased virulence in a mouse model of infection 
(Mercier, Howe et al. 1998). 
Endomembrane Trafficking Organelles 
Proteins are trafficked to their final destinations through an endomembrane 
system that consists of a single perinuclear endoplasmic reticulum (ER) and a 
single Golgi stack (Figure 1.3, below). Secretory proteins are targeted to this 
system by a signal recognition particle-dependent translocation pathway, which 
has been shown to be partially conserved between T. gondii and eukaryotic model 
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organisms (Sheiner and Soldati-Favre 2008). It is likely that transport between the 
ER and Golgi is mediated by COPI/COPII coated vesicles as in model eukaryotes, 
based on the functional conservation of sequences for targeting to these two 
compartments (Hoppe and Joiner 2000), though these proteins have not been 
characterized within the parasite. In contrast to higher eukaryotes, which can have 
hundreds of Golgi stacks, T. gondii maintains a single stack of 3-5 Golgi cisternae 
that is located directly adjacent to the ER exit site (Pelletier, Stern et al. 2002). 
From the Golgi, the default secretory pathway will take proteins either to the dense 
granules, discussed above, or the parasite plasma membrane (Karsten, Qi et al. 
1998, Striepen, He et al. 1998). Proteins targeted to the apicomplexan specific 
secretory organelles, the micronemes and rhoptries (discussed below) are 
recognized by a transmembrane Golgi protein, the sortilin-like receptor TgSORTL, 
which prevents them from following the default secretory pathway. This receptor 
recruits components of the protein transport machinery that instead allows these 
proteins to reach their final destination in the micronemes or rhoptries (Sloves, 
Delhaye et al. 2012). While transport into the mitochondrion occurs post-
translationally through translocons located in the mitochondrial membrane, 
transport to the other endosymbiont-derived organelle, the apicoplast, begins in 
the ER/golgi. Apicoplast proteins are targeted via a bipartite signal sequence that 
contains both a signal peptide to direct them to the ER and a transit peptide that 
directs them to the apicoplast (Yung and Lang-Unnasch 1999). Preliminary 
characterization of translocons localized to membranes of the apicoplast suggest 
that this organelle imports proteins using translocons similar to those found in 
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chloroplast membranes, as would be expected (van Dooren, Tomova et al. 2008, 
Sheiner, Fellows et al. 2015). For remaining organelles, such as the 
acidocalcisomes or the plant-like vacuole (PLV), it remains unclear how proteins 
are targeted to these locations, though at least one PLV-localized protein contains 
a predicted signal peptide, suggesting proteins targeted to this organelle also pass 
through the ER/golgi secretory system (LaFavers, Alveal, and Arrizabalaga, 
unpublished data). 
Ion Storage Organelles 
T. gondii contains multiple organelles that play important roles in ion 
homeostasis (Figure 1.3, below). The first of these, the acidocalcisome, is found 
in many other species including prokaryotes and eukaryotes and contains large 
amounts of oxygen, sodium, chlorine, potassium, zinc, phosphate, and 
magnesium in addition to the calcium that gives it its name (Luo, Vieira et al. 2001, 
Docampo, de Souza et al. 2005). The calcium stores within this organelle have 
been shown to be released in response to alkalinizing agents such as NH4Cl or 
proton ionophores such as nigericin or monensin (Moreno and Zhong 1996). 
Though the exact function of the acidocalcisome is unclear, the genetic ablation of 
a Ca2+-ATPase localized to the acidocalcisome results in elevated cytosolic 
calcium and decreased invasion of host cells, leading to decreased virulence in 
vivo, suggesting this organelle plays an important role in sequestering parasite 
calcium from the cytosol (Luo, Ruiz et al. 2005).  
The plant-like vacuole (PLV or VAC) is another organelle important for ion 
homeostasis. Proteins localized to this large vacuole include multiple proteases 
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hypothesized to be important for digestion of material acquired from the host cell 
by ingestion (Dou and Carruthers 2011), a Na+/H+ exchanger shown to be critical 
for normal calcium-dependent signaling processes (Francia, Wicher et al. 2011), a 
vacuolar proton pyrophosphatase (Rodrigues, Scott et al. 2000, Liu, Pace et al. 
2014), a vacuolar proton ATPase (Rodrigues, Ruiz et al. 2002) and a transporter 
with homology to the chloroquine resistance transporter found in Plasmodium’s 
digestive vacuole (Warring, Dou et al. 2014). It has been proposed that the PLV 
acts as an additional store for calcium due to the release of calcium into the cytosol 
in response to glycyl-L-phenylalanine-naphthylamide (GPN) (Moreno and Zhong 
1996). GPN is used in higher eukaryotes to measure lysosomal Ca2+ release 
since it is specifically hydrolyzed by cathepsin proteases found in lysosomes 
(Haller, Volkl et al. 1996, Srinivas, Ong et al. 2002). In T. gondii, these cathepsin  
 
Figure 1.3 T. gondii  tachyzoite with selected organelles drawn and 
identified.  
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proteases are found in the PLV, making it a likely source of Ca2+ release in 
response to GPN (Parussini, Coppens et al. 2010, Dou and Carruthers 2011). 
Phenotypes associated with disruption of PLV localized proteins can vary widely 
with genetic disruption of the Na+/H+ exchanger of the PLV resulting in 
increased sensitivity to osmotic stress (Francia, Wicher et al. 2011), while 
disruption of the L- type cathepsin protease (TgCPL) of the PLV results in 
accumulation of undigested host cell protein material (Dou, McGovern et al. 
2014). Together these disparate phenotypes suggest that the PLV is a 
multifunctional organelle that not only plays an important role in ion homeostasis 
but also in digesting proteins ingested from the host cell cytosol. 
Calcium Signaling in T. gondii 
Many of the events in T. gondii’s lytic cycle such as egress, motility, invasion 
and micronemal protein secretion are accompanied by and dependent on calcium 
fluxes within both the parasite and the host cell (Arrizabalaga and Boothroyd 
2004). Calcium levels increase in the host cell, the PV and the parasite cytoplasm 
just prior to the initiation of parasite egress from its host cell (Borges-Pereira, Budu 
et al. 2015). Oscillations in parasite calcium, which are enhanced in the presence 
of extracellular calcium, have been observed during periods of parasite motility 
using both chemical and genetically encoded calcium indicators (Lovett and Sibley 
2003, Borges-Pereira, Budu et al. 2015). Secretion of proteins from the 
micronemes, which are required for parasite attachment to a host cell, can be 
stimulated by artificially inducing calcium fluxes (Carruthers and Sibley 1999).  
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The parasite can access the calcium required for these signaling events 
from both intraparasitic calcium stores and the extracellular milieu once it has 
egressed from its host cell (Moreno, Ayong et al. 2011). T. gondii has been shown 
by transmission electron microscopy of precipitated calcium to store intracellular 
calcium within the perinuclear endoplasmic reticulum (ER) as well large  
 
Figure 1.4 Key steps in the lytic cycle of T. gondii are accompanied 
by fluctuations in calcium within the parasite and host cell 
1. Parasite cytosolic calcium increases stimulate the release of 
micronemal proteins required for efficient host cell attachment. 2. 
Invasion of the parasite is accompanied by a dramatic drop in 
parasite cytosolic calcium. 3. Host cell cytosolic calcium and 4. 
parasite cytosolic calcium increase just prior to egress of parasites 
to host cells. 5. The active motility of the parasite is accompanied 
by oscillations in parasite cytosolic calcium. 
cytoplasmic vacuoles, which likely are what has been referred to as plant like 
vacuoles (PLV), (Miranda, Pace et al. 2010), and within the flattened sacs of the 
inner membrane complex that lie just beneath the parasite plasma membrane 
(Bonhomme, Pingret et al. 1993). The localization of calcium stores within the ER 
is supported by pharmacological studies using triggers of ER calcium release, such 
as thapsigargin, which induce invasion related events including protein secretion 
and cytoskeletal rearrangement of the apical end of the parasite (Moreno and 
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Zhong 1996, Carruthers and Sibley 1999). Though the target of thapsigargin, the 
sarco-endoplasmic reticulum calcium ATPase, is conserved in T. gondii and 
localizes to the ER as predicted (Nagamune, Beatty et al. 2007), it is unclear 
whether or not additional channels involved in calcium release from the ER in 
higher eukaryotes have homologues in 
 
Figure 1.5 Conservation of Calcium Signaling in T. gondii 
ATP - adenosine triphosphate, ADP - adenosine diphosphate, RyR 
- Ryanodine Receptor, IP3- Inositol trisphosphate, IP3R - IP3 
Receptor 
the parasite (Figure 1.5, above). For example, the IP3 and Ryanodine (RyR) 
receptors that reside within and release calcium from the ER of eukaryotes from 
yeast to human do not have sequence homologues in T. gondii, despite the 
organism’s ability to respond to pharmacological agents that target these proteins 
in other species (Moreno, Ayong et al. 2011, Prole and Taylor 2011). As described 
above, there is pharmacological  evidence to support calcium storage within the 
PLV and acidocalcisomes (Moreno and Zhong 1996). The parasites can also 
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access calcium when extracellular; this calcium is likely taken up by a nifedipine-
sensitive calcium channel in the parasite plasma membrane, though the channel 
responsible for this uptake has not been identified (Pace, McKnight et al. 2014). 
Once inside a cell, the parasite divides within the PV, where it is presumed to have 
access to the host cell calcium through the presence of a nonselective pore in the 
PVM, though the exact molecular mechanism for calcium import from the PV 
lumen across the parasite plasma membrane has yet to be elucidated (Gold, 
Kaplan et al. 2015). Interestingly, electron microscopy analysis of intracellular 
tachyzoites suggests that calcium is concentrated within the TVN (Bonhomme, 
Pingret et al. 1993). Whether this accumulation of calcium within the TVN is an 
active process or if it plays a role in the parasite’s biology is not known. Calcium 
levels within the parasite and the PV are thought to remain relatively constant 
during the replicative phase of the parasite life cycle, with levels within the host 
cell, PV and parasite spiking just prior to egress to activate protein secretion and 
parasite motility and begin the lytic cycle over again (Borges-Pereira, Budu et al. 
2015). Interestingly, some PV-localized proteins seem to play a role in calcium-
dependent signaling processes, such as egress. GRA1 was initially identified as a 
highly abundant, calcium-binding protein found in the lumen of the PV, though its 
exact function is unclear since genetic disruption of this gene has not been 
successful (Cesbron-Delauw, Guy et al. 1989). An additional GRA protein, GRA22, 
that has not been shown to bind calcium directly, has nevertheless been shown to 
play a role in the timing of natural egress, as the loss of this protein results in early 
egress of parasites from host cells (Okada, Marmansari et al. 2013). 
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Though many of the key molecular mechanisms and factors that respond 
to calcium during the invasion and egress of T. gondii have been identified, how 
the parasite detects and regulates the calcium fluxes is not completely understood. 
In this context, ionophores such as ionomycin, A23187, and nigericin have been 
instrumental in studying calcium signaling in T. gondii (Mondragon and Frixione 
1996, Pingret, Millot et al. 1996, Stommel, Ely et al. 1997, Black, Arrizabalaga et 
al. 2000, Arrizabalaga, Ruiz et al. 2004, Fruth and Arrizabalaga 2007, Caldas, de 
Souza et al. 2010). These ionophores are carrier ionophores which can exchange 
Ca2+ (ionomycin, A23187) or K+ (nigericin) ions for H+ ions across membranes until 
the ions reach electrochemical equilbirum (Pressman 1976). Brief (<2 minute) 
treatment of intracellular parasites with the calcium ionophores ionomycin or 
A23187 results in rapid exit from the host cell, a process known as ionophore 
induced egress (iiEgress). In contrast, treatment of intracellular parasites with 
nigericin requires a much longer treatment of 30 minutes before 100% of vacuoles 
have left their host cells, but it is likely that nigericin causes the activation of 
signaling pathways that lead to the eventual release of calcium to trigger egress, 
since mutants delayed in responding to calcium fluxes do not undergo egress in 
response to nigericin (Fruth and Arrizabalaga 2007). Brief treatment (2-5 min) of 
extracellular parasites with calcium ionophore A23187 induces micronemal 
secretion and parasite motility (Carruthers and Sibley 1999).  When treatment with 
ionophore A23187 is prolonged (45-60 min for Type I strains), the parasites lose 
their ability to attach and invade host cells, resulting in parasite death (ionophore 
induced death, iiDeath) (Mondragon and Frixione 1996, Black, Arrizabalaga et al. 
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2000). In an effort to identify the proteins that allow T. gondii to respond to calcium, 
former members of the Arrizabalaga and Boothroyd laboratories have exploited 
these calcium ionophore induced phenomena to isolate mutants with altered 
sensitivity to A23187. From a series of selections and screens six independent 
mutants have been isolated that fall into three phenotypic categories: delay in 
iiEgress and resistance to iiDeath, delay in iiEgress but normal sensitivity to 
iiDeath, and resistance to iiDeath but normal iiEgress (Black, Arrizabalaga et al. 
2000, Lavine, Knoll et al. 2007). Members of the Arrizabalaga laboratory have 
previously reported that all mutants that are both delayed in iiEgress and resistant 
to extracellular ionophore death have causative mutations in a calcium dependent 
protein kinase, TgCDPK3, which regulates egress by phosphorylating the major 
motor driving T. gondii motility (Garrison, Treeck et al. 2012, Gaji, Johnson et al. 
2015).  
To understand how T. gondii responds to calcium fluxes I focused our 
attention to the mutant strain MBD2.1, which is able to survive prolonged exposure 
to the ionophore while extracellular, but has no delay in iiEgress. Besides 
ionophore resistance, this mutant strain also exhibited hypersensitivity to treatment 
of extracellular parasites with the intracellular calcium chelator BAPTA-AM, 
suggesting that it has altered calcium homeostasis or sensitivity (Black, 
Arrizabalaga et al. 2000). Here I describe how these phenotypes are due to a 
nonsense mutation in a previously uncharacterized protein, GRA41, which 
localizes to the parasites’ secretory organelles known as dense granules and is 
secreted into the PV, where it associates with the TVN. Importantly, I also show 
 28 
that GRA41 is critical for calcium homeostasis and the timing of natural non-
induced egress. In conjunction, our findings suggest a connection between the 
TVN and ion homeostasis within parasite, and thus a novel role for the vacuole of 
this important pathogen.  
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Chapter 2 : Methods 
Parasite propagation 
T. gondii tachyzoites were propagated by passaging in human foreskin 
fibroblasts (HFFs, purchased from the American Tissue Culture Collection, ATCC) 
in a humidified incubator maintained at a temperature of 37°C and 5% CO2 
concentration. Normal growth medium used was Dulbecco’s Modified Eagle 
Medium (DMEM) with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 50 
μg/mL penicillin-streptomycin. 
Genome sequencing and complementation  
Preparation of genomic DNA was done by previous members of the 
Arrizabalaga laboratory. Extracellular parasites from strains MBD2.1 and 
RH∆hxgprt (the parental strain) were purified through a 3 μm filter to eliminate 
human cell contamination. Genomic DNA from both strains was isolated using the 
DNeasy Blood and Tissue Kit (Qiagen). Sample preparation, sequencing, genome 
assembly, and annotation was performed at the University of Idaho IBEST 
Genomics Resources Core facility. Genomic DNA libraries were constructed using 
the Illumina TruSeq library kit and quantified with rtPCR using the Kapa Illumina 
library quantification kit. 100bp paired-end Illumina sequencing was used to an 
estimated > 100x coverage per genome. Mapping of Illumina sequence was 
performed using GMAP to the TGGT1 reference sequence from ToxoDB (Gajria, 
Bahl et al. 2008) with output to SAM format files for further processing.  Genomic 
variants in the mutant strains in comparison to the reference sequence were 
detected and extracted from the mapped data using the Broad institutes GATK 
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toolkit. Data was exported as a variant call format (VCF) file, which listed each 
genomic variant, its position in the genome, and the quality of sequence data for 
that particular region. In total 14 SNVs were detected between the mutant and 
parental strain. The two SNVs that resulted in missense or nonsense mutations in 
MBD2.1 were confirmed by sequencing fragments of genomic DNA amplified by 
PCR from both the parental and mutant strains and that spanned regions with 
putative mutations.  
To determine which of the identified variants in the mutant was responsible 
for the phenotype, a cosmid-based complementation approach was used. 
Cosmids generated from the RH (Type I strain) containing the genomic regions of 
interest were identified on ToxoDB.org and were graciously provided by Dr. David 
Sibley at Washington University, St. Louis. For TGGT1_069070 cosmid TOXO119 
was linearized by digestion with NotI (New England Biolabs), purified and 
electroporated into T. gondii tachyzoites of the MBD 2.1 mutant according to 
established protocols (Kim, Soldati et al. 1993, Soldati and Boothroyd 1993). 
Transfected parasites were maintained in the presence of 1 μM pyrimethamine 
prior to cloning by limiting dilution to select for stable transformants. 
iiDeath survival assay 
The iiDeath survival assay was performed as described previously (Black, 
Arrizabalaga et al. 2000). In brief, intracellular parasites were harvested by 
passage through a 27 gauge needle three times before dilution and treatment with 
either 1 μM A23187 or DMSO solvent control for 45 or 60 minutes (10 or 30 
minutes for Type II strains) in a humidified incubator at 37°C and 5% CO2 
 31 
concentration. At each time point, 500 parasites were removed from the treatment 
and allowed to infect a confluent monolayer of HFFs in a twelve well plate format 
for two hours before changing the media to remove uninvaded parasites. Parasites 
were allowed to grow and form plaques for 6 days before the cultures were fixed 
and scored. Each combination of treatment and time point was the average of a 
minimum of three technical replicates per experiment and the experiments were 
performed a minimum of three times for statistical analysis. The percent survival 
for each strain and time point was calculated as a ratio of the number of plaques 
scored in the wells infected with treated parasites as compared to the wells 
infected with untreated (DMSO solvent control) parasites. 
Micronemal secretion assay 
Micronemal protein secretion was assessed by suspending extracellular 
parasites at a concentration of 1x109/mL in complete DMEM. Calcium ionophore 
A23187 or DMSO control was added to each sample to a final concentration of 1 
μM and incubated at 37°C for one hour. Parasites were separated from secreted 
proteins in the media by centrifugation at 3,000 x g’s for 3 minutes at 4°C. The 
resulting supernatant was subjected to a second spin under the same conditions 
to ensure all of the parasite pellet was removed from the sample. The pellets were 
resuspended in 2X Laemmli Sample Buffer (Bio-Rad) with 5% freshly added 
betamercaptoethanol (BME) to a final concentration of 1x109/mL and treated as 
described in Western Blot analysis (below). Supernatants were combined with 4X 
Laemmli Sample Buffer (Bio-Rad) with 10% freshly added BME and treated as 
described in Western blot analysis. The resulting Western blots were probed with 
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mouse anti-MIC2 antibody to detect endogenous MIC2 protein (Wan, Carruthers 
et al. 1997) and visualized as described in Western Blot analysis.  
Generation of Type I endogenously tagged GRA41 line 
For the expression of GRA41 tagged with hemagglutinin at the carboxyl 
terminal of the encoded protein, an 800 base pair fragment of parasite genomic 
DNA was amplified by PCR with specific primers GRA41 Tag.FOR and GRA41 
Tag.REV (see Table 2.1, for sequence of all primers used in this study) and 
directionally cloned into the PacI site of the 3xHA.Lic.DHFR-TS plasmid using In-
Fusion Cloning (Clontech). The 3xHA.LIC.DHFR-TS plasmid is a derivative of the 
YFP.LIC.DHFR-TS plasmid (Huynh and Carruthers 2009) with the YFP coding 
sequence replaced by a triple hemagglutinin tag. The resulting construct was 
verified by restriction digestion and sequencing. The plasmid construct was 
linearized with the restriction enzyme XcmI, which cuts within the region containing 
the insert and allows for integration of the construct by single homologous 
recombination when transfected into the RH∆ku80 strain (Huynh and Carruthers 
2009). T. gondii tachyzoites were transfected with the linearized vector by 
electroporation according to established protocols (Soldati and Boothroyd 1993). 
Transfected parasites were maintained in the presence of 1 μM pyrimethamine 
prior to cloning by limiting dilution to select for stable transformants. 
Immunofluorescence assays 
For immunofluorescence assays, HFFs grown on glass coverslips infected 
18-24 hours prior were fixed with 3.5% methanol-free formaldehyde in PBS, 
blocked in PBS/3% BSA and permeabilized in PBS/3% BSA/0.2% TX-100. 
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Samples were then incubated in primary antibodies (Rabbit anti-HA, Cell Signaling 
Technology, mouse anti-Gra1, Biotem) diluted in PBS/3% BSA/0.2% TX-100, 
washed and then incubated in secondary antibodies (goat anti-mouse/rabbit 
Alexafluor 488/594 conjugated, Invitrogen) diluted in PBS/3% BSA. Coverslips 
were mounted onto microscope slides with Vectashield mounting media containing 
DAPI (Vector Laboratories). IFAs were inspected using a Nikon Eclipse E100080i 
microscope and images captured with a Hamamatsu C4742-95 charge-coupled 
device camera using NIS elements software. 
Western blot analysis 
To examine protein expression by Western blot, parasites were lysed in 150 
mM NaCl, 50 mM Tris-Cl, pH 7.5, 0.1% NP-40 for a minimum of twenty minutes. 
Samples were centrifuged at 14,000 x g’s for 20 minutes to remove insoluble 
proteins before combining with an equal amount of 2X Laemmli Sample Buffer 
(Bio-Rad) with freshly added 5% BME (Thermo Scientific) and heating at ~95°C 
for 5 minutes. Samples were separated on a 4-20% gradient SDS-PAGE gel (Bio-
Rad) before transferring to a nitrocellulose membrane using a Trans-Blot semi-dry 
transfer cell (Bio-Rad). Nitrocellulose membranes were blocked for a minimum of 
30 minutes in Tris-buffered saline/tween (TBST) with 5% non-fat dry milk (NFDM) 
before being probed with Rabbit anti-HA at a dilution of 1:5000 (Cell Signaling 
Technologies), mouse anti-ROP1 at a dilution of 1:5000 (Schwartzman and Krug 
1989) or mouse anti-SAG1 at a dilution of 1:5000 (Genway) for a minimum of one 
hour. They were then washed a minimum of three times for ten minutes with TBST 
before incubating with the appropriate horse radish peroxidase conjugated 
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secondary antibody (Sigma) for one hour. Membranes were washed again before 
incubating with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo 
Scientific) for five minutes. Blots were imaged using the FluorChem E system 
(Protein Simple) for analysis of chemiluminescent Western blots.  
Triton-X 114 membrane partitioning 
Membrane partitioning of lysates with Triton-X 114 (Sigma-Aldrich) was 
performed as described previously (Rome, Beck et al. 2008). Briefly, parasites 
were lysed in 10% Triton-X 114, 10 mM Tris, pH 7.4, 5 mM NaCl on ice for 30 
minutes, before centrifuging the samples at 2500 x g’s for five minutes before 
removing the supernatant to a new tube for partitioning. Lysates were incubated 
at 30°C for five minutes, followed by centrifugation at 3,000 x g’s for 5 minutes to 
separate samples into the aqueous and detergent phases. The aqueous phase 
was re-extracted by incubating with 10% Triton-X 114, 10 mM Tris, pH 7.4, 5 mM 
NaCl on ice for 5 minutes, then at 30°C for five minutes, followed by centrifugation 
as described above. The detergent phase was re-extracted by incubating with PBS 
on ice for 5 minutes, then at 30°C for five minutes, followed by centrifugation as 
described above. Proteins were precipitated from the final aqueous and detergent 
phases by adding two volumes of ice cold acetone to each sample and incubating 
at -20°C for a minimum of two hours, followed by centrifugation at 15,000 x g’s for 
ten minutes. The resulting pellets were washed once more with ice cold acetone 
before they were resuspended in 2X Laemlli Sample Buffer (Bio-Rad) with freshly 
added 5% BME (Thermo Scientific) and processed for Western blot analysis as 
described above. 
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Electron microscopy 
For transmission electron microscopy, confluent monolayers of HFFs were 
infected with parasites of the strain of interest 24 hours prior to sample preparation. 
Infected cells were washed four times with PBS before fixing for one hour in freshly 
prepared 2.5% glutaraldehyde in 100 mM sodium cacodylate, pH 7.4 buffer in the 
dark. Fixative was then removed and samples were washed three times with PBS 
before being harvested by gentle scraping followed by centrifugation at 3,000xg’s 
for 10 minutes. The pellets were then incubated in 1% osmium tetroxide in 100 
mM sodium cacodylate pH 7.4 buffer that had been reduced by adding solid 
potassium ferrocyanide to a final concentration of 1.5% (w/v) and incubated in the 
dark at 4 °C for one hour. The pellets were washed three times with 100 mM 
sodium cacodylate, pH 7.4 buffer before dehydration in a series of ethanol washes. 
Pellets were dehydrated with five minute incubations in 30%, 50%, 70%, 90% and 
95% ethanol followed by four five minute washes of 100% ethanol. The samples 
were infiltrated with Embed-812/Araldite 502 resin (Electron Microscopy 
Sciences), at a dilution of 1:1 resin with 100% ethanol and in 3 changes of 100% 
resin. The formulation of resin used was 12.5 ml Embed-812, 7.5 ml Araldite-502, 
27.5 ml Dodecenyl Succinic Anhydride, and 0.95 ml DMP-30. All resin incubations 
were for at least 2 hours and were done at room temperature in a rotator at low 
speed. After the final change the inserts were polymerized at 65 degrees Celsius. 
Remaining steps were done with the assistance of the Indiana University-
Blomington Electron Miroscopy Center (http://iubemcenter.indiana.edu). Thin 
sections were obtained using a diamond knife, mounted on copper grids and 
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stained with uranyl acetate and lead citrate before imaging on a JEOL 1010 
transmission electron microscope. Images were captured with a 1k x 1k Gatan 
CCD camera (MegaScan model 794) and a tungsten filament was used as an 
electron source. 
For immunoelectron microscopy, HFFs infected with parasites for 24-36 
hours were washed three times with PBS before fixing for one hour in freshly 
prepared 4% paraformaldehyde (EM grade, VWR) in 250 mM HEPES pH 7.4. 
Fixative was then removed and replaced with a solution of 8% paraformaldehyde 
in 250 mM HEPES pH 7.4 for overnight incubation at 4°C. Samples were harvested 
by gentle scraping to detach sheets of cells followed by centrifugation at 2,000 rpm 
for 10 minutes. Additional steps were carried out by Dr. Isabelle Coppins of Johns 
Hopkins University. Infected cells were pelleted in 10% fish skin gelatin and the 
gelatin-embedded pellets were infiltrated overnight with 2.3 M sucrose at 4°C and 
frozen in liquid nitrogen. Ultrathin cryosections were incubated in PBS and 1% fish 
skin gelatin containing mouse anti-HA antibody at 1/250 dilution, and then exposed 
to the secondary antibody that were revealed with 10 nm protein A-gold 
conjugates. Sections were observed and images were recorded with a Philips 
CM120 Electron Microscope (Eindhoven, the Netherlands) under 80 kV. 
Generation of Type I GRA41 knockout strain 
The GRA41 knockout strain, RH∆ku80∆gra41, was generated by replacing 
the entire GRA41 coding sequence with the HXGPRT selectable marker by double 
homologous recombination in the RH∆ku80 parental strain (Huynh and Carruthers 
2009). The pGRA41KO vector was generated by cloning fragments approximately 
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1.5 kbp in length directly upstream (primers GRA41 KO 5’ Flank.FOR and GRA41 
KO 5’ Flank.REV, Table 2.1) and downstream (primers GRA41 KO 3’ Flank.FOR 
and GRA41 KO 3’ Flank.REV, Table 2.1) of the GRA41 coding sequence into the 
HindIII and NotI sites of the pMini vector (Donald, Carter et al. 1996) by In-Fusion 
cloning (Clontech). The resulting construct was verified by restriction digestion and 
sequencing. T. gondii tachyzoites were transfected with purified linearized vector 
by electroporation according to established protocols (Soldati and Boothroyd 
1993). Transfected parasites were maintained in the presence of 50 μg/ml 
mycophenolic acid and 50 μg/ml xanthine prior to cloning by limiting dilution to 
select for stable transformants. Individual clones were screened by PCR to verify 
correct replacement of the GRA41 locus with the HXGPRT selectable marker. To 
confirm the correct insertion, primers complementary to the 3’ end of the HXGPRT 
selectable marker and downstream of the insertion site were used to perform a 
PCR analysis of genomic DNA isolated from GRA41 knockout clones. A primer 
within the 3’ homology region of the pGRA41KO vector (p1, Figure 3.5, GRA41 
3’UTR Mid.FOR, Table 2.1) and one downstream of the insertion site (p3, Figure 
3.5, GRA41 Downstream.REV, Table 2.1) were used as a positive control, while a 
primer within the selectable marker of the pGRA41KO vector (p2, Figure 3.5, 
DHFR 3’UTR End.FOR, Table 2.1) was combined with the same downstream 
primer (p3) to identify clones with the desired incorporation of the pGRA41KO 
vector. Loss of GRA41 mRNA transcript was verified by qPCR analysis (primers 
GRA41 qPCR.FOR and GRA41 qPCR.REV, Table 2.1) using the SYBR Green  
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Primer Name Sequence 
Gra41 Tag.FOR TACTTCCAATCCAATTTAATGCAATAGAGACGC
AGCACCCTTG 
Gra41 Tag.REV TCCTCCACTTCCAATTTTAGCTTCGGGTAGGTG
AAGTTTAG 
Gra41 qPCR.FOR ACGGCAGCTTGAGATACCAC 
Gra41 qPCR.REV GCAGCCCTGGTATTGTATCG 
Gra41 KO 5'Flank.FOR CGGTATCGATAAGCTTTTTGGTGTGGGCCTGT
CGAAT 
Gra41 KO 5'Flank.REV CGTGCTGATCAAGCTTCCACGCGTGGATTGCA
GAAAA 
Gra41 KO 3' Flank.FOR AGTTCTAGAGCGGCCGCTTTTGGTACCTCCAT
GGGCAAGG 
Gra41 KO 3' Flank.REV ACCGCGGTGGCGGCCGCATACAAAGGCGAGG
TCATTGCTGTG 
GraX 41 3'UTR Mid.FOR GCGGATTTGTGGCTACAATACTGC 
Gra41 Downstream.REV CTGCTCTATGTCCTCTGTTCGATGT 
DHFR 3'UTR End.FOR GGCCATTCATGCCAGTCAGT 
TgGT1_236870 
qPCR.FOR  
TTGATGACGACGAGGATGAA 
TgGT1_236870 
qPCR.REV 
GTATGCGGGTAACGACGAGT 
TgGT1_236860 
qPCR.FOR  
TCTCGCGACAACATTTCAAG 
TgGT1_236860 
qPCR.REV 
GCTTTGTCTTCGCTTCCATC 
Gra41 qPCR.FOR ACGGCAGCTTGAGATACCAC 
Gra41 qPCR.REV GCAGCCCTGGTATTGTATCG 
RPL29 qPCR.FOR GGCGAAATCAAAGAACCACAC 
RPL29 qPCR.REV TCGGACTTCATCATGCCTCTC 
GRA41 pet28a.FOR CGCGCGGCAGCCATATGGACTGTATTCCTTCG
CATCAA 
GRA41 pet28a.REV GTCATGCTAGCCATATGTTATTCGGGTAGGTG
AAGTTTAGA 
Type II Gra41 Tag.FOR TTCCAATCCAATTTAATTAATTGAAATACACCCT
AGACGGCACAC 
Type II Gra41 Tag.REV CCACTTCCAATTTTAATTAATTTGGGTAGGTGA
AGTTCAGAAAGC 
Type II Gra41 KO 5’ 
Flank.FOR 
CGGTATCGATAAGCTTTTTGGTGTGGGCCTGT
CGAAT 
Type II Gra41 KO 5’ 
Flank.REV 
CGTGCTGATCAAGCTTCCACGCGTGGATTGCA
GAAAA 
Type II Gra41 KO 3’ 
Flank. FOR 
AGTTCTAGAGCGGCCGCTTTTGGTACCTCCAT
GGGCAAGG 
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detection reagent (Fast Syber Green Master Mix, Applied Biosystems). Relative 
gene expression was calculated by normalizing to levels of the housekeeping gene 
ribosomal protein 29 (TGGT1_2345500, Primers RPL29 qPCR.FOR and RPL29 
qPCR.REV, Table 2.1) Relative transcript abundance of the genes directly flanking 
GRA41 (TGGT1_236860 using primers TGGT1_236860 qPCR.FOR and 
TGGT1_236860 qPCR.REV and TGGT1_236870 using primers TGGT1_236870 
qPCR.FOR and TGGT1_236870 qPCR.REV, Table 2.1) was also measured by 
qPCR analysis to ensure that their levels did not differ significantly from the 
parental strain. 
Generation of GRA41 knockout complemented clones 
The GRA41 knockout strain, RH∆ku80∆gra41 was complemented by 
transfecting with the cosmid TOXO119 previously utilized for the complementation 
of mutant MBD2.1 described above. Complemented clones were selected for 
integration of the gene back into its original locus by selecting against the presence 
of the HXGPRT selectable marker using 80 μg/ml 6-thioxanthine. Following limited 
dilution cloning, individual clones were subjected to treatment with 50 μg/ml 
mycophenolic acid and 50 μg/ml xanthine and qPCR analysis of GRA41 transcript 
levels to identify clones which were either HXGPRT+GRA41- or HXGPRT-GRA41+. 
Transcript levels of GRA41 were normalized to the levels of ribosomal protein 
RPL29 as described above. 
Type II Gra41 KO 3’ 
Flank. REV 
ACCGCGGTGGCGGCCGCATACAAAGGCGAGG
TCATTGCTGTG 
Table 2.1 Name and sequence of primers used in this study. All 
sequences are 5’ to 3’. 
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Parasite growth assays 
Growth of all parasite strains was assessed by determining plaquing 
efficiency and growth rate as follows. Intracellular parasites were harvested from 
a confluent monolayer of HFFs by passage through a 27-gauge needle 2-3 times. 
Parasites were then diluted in normal growth medium and allowed to infect a 
confluent monolayer of HFFs and returned to a humidified incubator for two hours 
before changing the media to remove any uninvaded parasites. For plaque assays, 
parasites were allowed to form plaques for six days before the monolayer was 
fixed and stained with Crystal Violet (ACROS Organics) to visualize plaques. For 
doubling assays, parasites were allowed to grow for twelve, twenty-four and or 
thirty hours before they were fixed and stained with Hema3 Manual Staining 
System (Fisher) to count the number of parasites per vacuole for a minimum of 50 
vacuoles per sample.  
Parasite egress assays 
Egress in response to DTT treatment was assessed as follows. Parasites 
were allowed to invade host cells for 24 hours prior to the start of the assay. 
Infected monolayers were washed twice with 1X PBS and once with 1X HBSS 
(Invitrogen) before incubating in either 5 mM DTT in 1X HBSS or buffer only control 
for the required time. Monolayers were then fixed with methanol and stained with 
Hema3 Manual Staining System (Fisher) to assess parasite egress. 
Parasite invasion assays  
The efficiency of attachment and invasion for various parasite strains was 
measured as follows.  Intracellular parasites were harvested as for plaque assays.  
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Parasites were then diluted in normal growth medium and allowed to infect a 
confluent monolayer of HFFs for two hours. Unattached parasites were removed 
by washing with PBS three times. Cells were then fixed in 3.5% methanol-free 
formaldehyde before blocking in PBS/3% BSA. Prior to permeabilization, 
extracellular parasites were labeled with mouse anti-P30 antibody (Genway) for 
one hour in PBS/3% BSA. Cells were then washed to eliminate unbound antibody 
and permeabilized in PBS/3% BSA/0.2% TX-100 before incubation with rabbit anti- 
T. gondii (MyBioSource) for one hour. Cells were washed and then incubated with 
goat anti-mouse Alexa fluor 488 and goat anti-rabbit Alexa flour 594 (Invitrogen) 
for one hour before washing and mounting in Vectashield mounting media with 
DAPI (Vector Labs). Intracellular and extracellular parasites were distinguished 
between by the presence of dual-color staining (extracellular parasites) or single-
color staining (intracellular parasites, which only stain after permeabilization). The 
efficiency of attachment was calculated by counting the total number of parasites 
for ten random fields of view and normalizing to 100% attachment for the parental 
strain. The efficiency of invasion was calculated as the percentage of invaded 
(intracellular) parasites out of the total number of parasites. 
Calcium measurements 
Calcium measurements of free cytosolic calcium were done by Karla 
Marquez-Nogueras of the Moreno laboratory at the University of Georgia. Loading 
of parasites with Fura-2 was performed as previously described (Moreno and 
Zhong, 1996). Briefly, freshly egressed parasites were washed and then 
centrifuged twice at 500 x g’s for 10 minutes at room temperature in buffer A (116 
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mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.5 mM d-glucose and 50 mM HEPES, 
pH 7.4). Then, parasites were resuspended to a final density of 1x109 parasites/ml 
in Ringer buffer (155 mM NaCl, 3 mM KCl, 1 mM MgCl2, 3 mM NaH2PO4H2O, 10 
mM HEPES, pH 7.3, and 5 mM glucose; plus 1.5% sucrose and 5 μM of Fura-2-
AM). The suspension was incubated for 26 minutes in a 26°C water bath with mild 
agitation. Subsequently, the parasites were washed twice with Ringer’s buffer to 
remove extracellular dye. Parasites were resuspended to a final density of 1x109 
parasites/ml in Ringer’s buffer and kept on ice. Parasites are known to be viable 
for a few hours under these conditions (Pace, McKnight et al. 2014). For 
fluorescence measurements, 2x107 parasites/mL were added to a cuvette with 2.5 
mL of Ringer’s buffer. Cuvette was placed in a thermostatically controlled Hitachi 
F-7000 fluorescence spectrophotometer, using the conditions for Fura-2 excitation 
(340 and 380nm) and emission (510nm). The Fura-2 fluorescence response to 
intracellular Ca2+ concentration ([Ca2+]i) was calibrated from the ratio of 340/380 
nm fluorescence values after subtraction of the background fluorescence of the 
cells at 340 and 380 nm as previously described (Grynkiewicz et al., 1985). 
Changes in [Ca2+]i (ΔF [Ca2+]) were measured by subtracting the highest peak of 
calcium in the first 50 seconds after addition of calcium minus the baseline.  
Recombinant protein production 
The GRA41 recombinant expression vector was generated by cloning the 
GRA41 coding sequence without the signal peptide into the pet28a (+) vector 
(EMD Biosciences) using In-fusion Cloning (Clontech). The GRA41 coding 
sequence was amplified using primers GRA41 pet28a.FOR and GRA41 
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pet28a.REV (Table 1) and inserted into the NdeI sites of the pet28a (+) vector. The 
resulting construct was verified by restriction digestion and sequencing. Rosetta 
(DE3) pLysS E. coli BL21 competent cells (Novagen) were transformed with 
purified vector according to the manufacturer’s protocol. Transformed cells were 
then grown at 37°C in LB media to an O.D. of 0.6 before inducing protein 
expression with 1 mM IPTG for 3 hours. After induction, cells were harvested by 
centrifugation at 10,000 x g’s for 20 minutes at 4°C. Pellets were stored at -80°C. 
Additional steps were done with the assistance of Dr. Sanofar Abdeen of the 
Johnson laboratory at Indiana University School of Medicine. Pellets were 
resuspended in ~100 mL of lysis buffer (50 mM Tris-HCl, pH 7.4, 10 mM MgSO4, 
1 mM beta-mercaptoethanol, 0.1% Triton-X 100, 5% glycerol) before adding 
lysozyme to a final concentration of 50 μg/mL and incubating for ten minutes on 
ice. Samples were then sonicated on ice for six minutes (10 seconds on, twenty 
seconds rest) before removing the insoluble portion by centrifugation at 14,000 x 
g’s for 30 minutes at room temperature. The supernatant was filtered through a 
0.45 µm filter before purifying on a 5 ml HisTrap HP Nickel column (GE) on a NGC 
Quest FPLC (Bio-Rad). Fractions were collected analyzed by SDS-PAGE and 
Western Blot to determine purity. Fractions positive for the His-tagged protein were 
combined and further purified using a HiLoad 26/600 Superdex 200 size exclusion 
column (GE).  
Calcium thermal shift assays 
Differential scanning fluorimetry was utilized to measure the ability of 
calcium ions to bind to and stabilize the secondary structures of recombinant 
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proteins as described in (Niesen, Berglund et al. 2007) using recombinant CDPK3 
(Gaji, Johnson et al. 2015) as a positive control. N-terminally His tagged GRA41 
(final concentration of 8 μM) or CDPK3 (final concentration of 3.5 μM) in 100 mM 
HEPES, pH 7.0, 150 mM NaCl was incubated with 4X Sypro Orange (Sigma 
Aldrich) and CaCl2 in a two-fold dilution series ranging from 0-250 μM. Melt curve 
analysis was performed from 25 to 99°C with 1°C steps on a StepOne Plus Real-
Time PCR System (Applied Biosystems). Data were analyzed in Prism (GraphPad) 
to determine melting temperatures for each condition. 
Immunoprecipitation 
Human foreskin fibroblasts were infected with the strain containing an 
endogenous HA tag at the C terminus of GRA41 for twenty-four hours before 
harvesting. Samples were harvested by scraping the infected monolayer and 
solubilizing in RIPA buffer (10 mM Tris-Cl, pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 
1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl) with 
added protease inhibitors (cOmplete Mini Protease Inhibitor Cocktail, Roche) for a 
minimum of twenty minutes with rotation. Samples were sonicated for ten second 
pulses 2-3 x, with a minimum rest on ice of twenty seconds between pulses. 
Insoluble material was removed by centrifuging for 20 minutes at 13,000 x g’s and 
4°C. The supernatant was removed and incubated with high affinity rat anti-HA 
antibody (Roche) overnight at 4°C with rotation. The following morning, the 
antibody/antigen complex was bound to Protein G-conjugated Dynabeads 
(Invitrogen) by incubating the supernatant/antibody mixture with freshly washed 
Dynabeads for ten minutes at room temperature with rotation. The precipitated 
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beads were isolated using a magnet and washed three times with RIPA buffer plus 
protease inhibitors. Proteins were eluted from the beads by adding 2X Laemmli 
sample buffer with 5% betamercaptoethanol to the beads and incubating at 95°C 
for ten minutes. The beads were isolated using a magnet and the sample buffer 
containing eluted antigen was removed. The sample was run on a 4-20% Mini 
Protean TGX Precast Gel (Bio-rad) and the gel was stained using the Pierce Silver 
Stain kit (ThermoFisher Scientific). Regions containing visible bands were excised 
with a clean razor blade and stored in PBS before mass spectrometry analysis. 
Additional steps were performed by the Indiana University Bloomington Laboratory 
for Biological Mass Spectrometry (http://www.chem.indiana.edu/bms/). The 
samples were reduced with 10 mM DTT in 10 mM ammonium bicarbonate and 
then alkylated with 55 mM iodoacetamide (prepared in 10 mM ammonium 
bicarbonate). Alkylated samples were digested by trypsin (Promega) overnight at 
37°C. Digested peptides were injected onto the C18 column. Peptides were eluted 
with a linear gradient from 3 to 40% acetonitrile (in water with 0.1% FA) developed 
over 70 min at room temperature at a flow rate of 300 nL/min, and effluent was 
electro-sprayed into the mass spectrometer. A blank was run prior to and between 
the sample runs to make sure there was no significant signal from solvents, column 
or carryovers. Database search was carried out using SequestTM algorithms 
against the UniProt database for T. gondii. The results were further refined by 
removing hits with an expect value>0.0025. Common contaminants found in other 
unrelated datasets were removed and the list was restricted to proteins with a 
predicted signal peptide.  
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Yeast two hybrid screen 
Yeast two-hybrid screening was performed by Hybrigenics Services, 
S.A.S., Paris, France (http://www.hybrigenics-services.com). The coding 
sequence for T. gondii GRA41 (amino acids 25-179) was PCR-amplified and 
cloned into pB66 as a C-terminal fusion to the Gal4 DNA-binding domain (Gal4-
Gra41). The construct was checked by sequencing the entire insert and used as a 
bait to screen a random-primed T. gondii wild-type RH strain cDNA library 
constructed into pP6. pB66 derives from the original pAS2ΔΔ vector (Fromont-
Racine, Rain et al. 1997) and pP6 is based on the pGADGH plasmid (Bartel, Chien 
et al. 1993). 
62.4 million clones (6-fold the complexity of the library) were screened using 
a mating approach with YHGX13 (Y187 ade2-101::loxP-kanMX-loxP, mat-alpha) 
and CG1945 (mata) yeast strains as previously described (Fromont-Racine, Rain 
et al. 1997). 337 His+ colonies were selected on a medium lacking tryptophan, 
leucine and histidine and supplemented with 0.5 mM 3-aminotriazole to handle bait 
autoactivation. The prey fragments of the positive clones were amplified by PCR 
and sequenced at their 5’ and 3’ junctions. The resulting sequences were used to 
identify the corresponding interacting proteins in the GenBank database (NCBI) 
using a fully automated procedure. A confidence score (PBS, for Predicted 
Biological Score) was attributed to each interaction as previously described 
(Formstecher, Aresta et al. 2005). The PBS relies on two different levels of 
analysis. Firstly, a local score takes into account the redundancy and 
independency of prey fragments, as well as the distribution of reading frames and 
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stop codons in overlapping fragments. Secondly, a global score takes into account 
the interactions found in all the screens performed at Hybrigenics using the same 
library. This global score represents the probability of an interaction being 
nonspecific. For practical use, the scores were divided into four categories, from A 
(highest confidence) to D (lowest confidence). A fifth category (E) specifically flags 
interactions involving highly connected prey domains previously found several 
times in screens performed on libraries derived from the same organism. Finally, 
several of these highly connected domains have been confirmed as false-positives 
of the technique and are now tagged as F. The PBS scores have been shown to 
positively correlate with the biological significance of interactions (Rain, Selig et al. 
2001, Wojcik, Boneca et al. 2002). 
Generation of Type II endogenously tagged GRA41 line 
For the expression of GRA41 tagged with hemagglutinin at the carboxyl 
terminal of the encoded protein, an 1700 base pair fragment of Pru genomic DNA 
was amplified by PCR with specific primers Type II GRA41 Tag.FOR and Type II 
GRA41 Tag.REV (see Table 2.1, for sequence of primers used in this study) and 
directionally cloned into the PacI site of the 3xHA.Lic.DHFR-TS plasmid using In-
Fusion Cloning (Clontech). The 3xHA.LIC.DHFR-TS plasmid is a derivative of the 
YFP.LIC.DHFR-TS plasmid (Huynh and Carruthers 2009) with the YFP coding 
sequence replaced by a triple HA tag. The resulting construct was verified by 
restriction digestion and sequencing. The plasmid construct was linearized with 
the restriction enzyme XcmI, which cuts within the region containing the insert and 
allows for integration of the construct by single homologous recombination when 
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transfected into the Pru∆ku80 strain (Fox, Falla et al. 2011) stably expressing 
luciferase, which can be used to visualize parasite propagation in mice using a 
bioluminescence-based imaging system (Saeij, Boyle et al. 2005). T. gondii  
tachyzoites were transfected with the linearized vector by electroporation 
according to established protocols (Soldati and Boothroyd 1993). Transfected 
parasites were maintained in the presence of 1 μM pyrimethamine prior to cloning 
by limiting dilution to select for stable transformants. 
Generation of Type II GRA41 knockout strain 
The GRA41 knockout strain, Pru∆ku80∆gra41, was generated by replacing 
the entire GRA41 coding sequence with the HXGPRT selectable marker by double 
homologous recombination in the Pru∆ku80∆hxgprt parental strain(Fox, Falla et 
al. 2011). The pGRA41KO-GFP vector was generated by cloning fragments 
approximately 1.5 kbp in length directly upstream (primers Type II GRA41 KO 5’ 
Flank.FOR and Type II GRA41 KO 5’ Flank.REV, Table 2.1) and downstream 
(primers Type II GRA41 KO 3’ Flank.FOR and Type II GRA41 KO 3’ Flank.REV, 
Table 2.1) of the GRA41 coding sequence into the HindIII and NotI sites of the 
pmini-GFP.ht vector (Donald, Carter et al. 1996, Arrizabalaga, Ruiz et al. 2004) by 
In-Fusion cloning (Clontech). The resulting construct was verified by restriction 
digestion and sequencing. T. gondii tachyzoites were transfected with purified 
linearized vector by electroporation according to established protocols (Soldati and 
Boothroyd 1993). Transfected parasites were maintained in the presence of 50 
μg/ml mycophenolic acid and 50 μg/ml xanthine prior to cloning by limiting dilution 
to select for stable transformants. Individual clones were screened first for the 
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presence of GFP by live imaging (constructs integrated by double homologous 
recombination should be GFP negative) and then by PCR to verify correct 
replacement of the GRA41 locus with the HXGPRT selectable marker. 
To confirm the correct insertion, primers complementary to the 3’ end of 
HXGPRT selectable marker and downstream of the insertion site were used to 
perform a PCR analysis of genomic DNA isolated from GRA41 knockout clones. 
A primer within the 3’ homology region of the pGRA41KO vector (p1, Figure 5.2, 
GRA41 3’UTR Mid.FOR, Table 2.1) and one downstream of the insertion site (p3, 
Figure 5.2, GRA41 Downstream.REV, Table 2.1) were used as a positive control, 
while a primer within the selectable marker of the pGRA41KO vector (p2, Fig. 3, 
DHFR 3’UTR End.FOR, Table 2.1) was combined with the same downstream 
primer (p3) to identify clones with the desired incorporation of the pGRA41KO 
vector.  
Bradyzoite differentiation assays 
The ability of parasite strains to differentiate from tachyzoites to bradyzoites 
was assessed as follows. Intracellular parasites were harvested from a confluent 
monolayer of HFFs by passage through a 27-gauge needle 2-3 times. Parasites 
were then diluted in normal growth medium and allowed to infect a confluent 
monolayer of HFFs grown on glass coverslips and returned to a humidified 
incubator for two hours before replacing the media with RPMI switching media 
(RPMI 1640, Invitrogen, pH 8.1, 5% FBS, 50 mM HEPES), placing inside an 
airtight container and placing in a CO2 deprivation incubator at 37°C. At 4 or 7 
days, the cells were fixed, blocked, permeabilized and probed as described in the 
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immunofluorescence assay methods above. Rhodamine-labeled Dolichos biflorus 
agglutinin (DBA, Vector Laboratories) was added at a dilution of 1:250 during the 
secondary fluorophore-conjugated antibody step to stain the bradyzoite tissue cyst 
wall. Coverslips were mounted onto microscope slides with Vectashield mounting 
media that included DAPI (Vector Laboratories). IFAs were inspected using a 
Nikon Eclipse E100080i microscope and a minimum of 100 vacuoles for each 
strain and timepoint were scored as either cyst-wall positive or cyst-wall negative. 
The percentage of cyst wall positive vacuoles was expressed as a percentage of 
the total. 
Mouse studies of chronic toxoplasmosis 
The ability of parasites to disseminate and form tissue cysts in vivo was 
tested as follows. Intracellular parasites were washed 2-3 times with sterile PBS 
before being harvested from a confluent monolayer of HFFs by passage through 
a 27-gauge needle 2-3 times. Host cell debris was removed by passage through a 
3 μm filter. Parasites were counted and diluted in sterile PBS and transported at 
room temperature to the animal facility. Insulin syringes (28 gauge, Becton 
Dickinson) were used to deliver 100 μl of diluted parasite intraperitoneally to female 
CBA/J mice. Mice were monitored daily during the acute phase of the disease (up 
to 14 days) and 2-3x a week thereafter for signs of sickness. Two mice were lost 
during the course of the study (one each in the highest dose for the parental and 
knockout strains), but due to injuries sustained by the mice and the lack of recently 
observed acute symptoms of toxoplasmosis (ruffled coats, swollen abdomen, 
lethargy or difficulty walking), it was deemed that these mice did not perish as a 
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direct result of infection and they were removed from further analysis. At 28 days 
post-infection, mice were anesthetized in a CO2 chamber followed by cervical 
dislocation. Blood was collected for serum analysis and the brains were harvested 
to measure cyst burden. Brains were placed in Eppendorf tubes on ice for the 
remainder of the procedure. Each brain was ground in 1500 μl of ice-cold PBS 
using a mortar and pestle before removing 250 μl for immunofluorescence 
analysis. The remainder was immediately placed at -80°C for long-term storage. 
Samples were centrifuged at 3,000 x g’s for 5 minutes at room temperature and 
the supernatants removed. Brain tissue was resuspended in 150 μl of freshly 
prepared 3% formaldehyde in PBS and let stand for 20 minutes at room 
temperature prior to centrifugation at 3,000 x g’s for 5 minutes at room 
temperature. The supernatant was removed and brains were resuspended in 150 
μl of 100 mM glycine in PBS and let stand for 5 minutes at room temperature prior 
to centrifugation at 3,000 x g’s for 5 minutes at room temperature. The supernatant 
was removed and brains were resuspended in 150 μl of 3% BSA/0.2% TX-100 in 
PBS and let stand overnight at 4°C prior to centrifugation at 3,000 x g’s for 5 
minutes at room temperature. The supernatant was removed and brains were 
resuspended in 125 μl of 3% BSA/0.2% TX-100 in PBS containing a 1:250 dilution 
of Rhodamine-labeled DBA (Vector Laboratories) and let stand for one hour at 
room temperature prior to centrifugation at 3,000 x g’s for 5 minutes at room 
temperature. The brains were washed three times by resuspending in 150 μl of 
wash buffer (0.2% TX-100 in PBS) followed by centrifugation at 3,000 x g’s for 5 
minutes at room temperature. After the final centrifugation, the supernatant was 
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removed and 5 μl of brain material was pipetted onto three microscope slides per 
brain using a large bore pipette. Brains were gently flattened by placing a coverslip 
over the top and pressing down gently. Coverslips were secured with clear nail 
polish. The number of cysts per slide was enumerated using a Nikon Eclipse 
E100080i microscope. The total number of cysts for the three slides for each 
mouse was combined and multiplied by 26 to obtain an estimate of the total 
number of cysts per mouse brain as described previously (Lavine, Knoll et al. 
2007). 
Serum was collected by allowing the mouse blood to coagulate at room 
temperature for a minimum of thirty minutes in an Eppendorf tube. Serum was 
separated from coagulated blood cells by centrifuging twice at 4°C for 10 minutes 
at 5,000 x g’s. The resulting serum was used in a dot blot assay to verify that mice 
had been successfully infected. The dot blot assay was conducted as described 
previously (Benmerzouga, Checkley et al. 2015). Briefly, approximately 5 x 106 
freshly egressed parasites of the parental strain, Pru∆ku80, were centrifuged at 
room temperature for 10 minutes at 1,000 x g’s. All but 100 μl of the supernatant 
was removed and the parasites were resuspended in the remaining volume. 
Approximately 8-10 μl of resuspended parasites were pipetted onto a nitrocellulose 
membrane that had been soaked in PBS for 5 minutes. The resuspended parasites 
were allowed to dry onto the membrane before blocking the membrane with 
TBST/5% NFDM for 45 minutes. Individual blots were incubated with serum from 
a single mouse overnight at 4°C at a dilution of 1:50 in TBST/5% NFDM. The 
following morning, blots were washed three times with TBST for ten minutes each 
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before incubating with goat anti-mouse conjugated to horse radish peroxidase at 
a dilution of 1:5000 for a minimum of one hour at room temperature. Blots were 
again washed three times with TBST for ten minutes each before incubating for 
five minutes with SuperSignal West Femto Maximum Sensitivity Substrate 
(Thermo Scientific) for five minutes. Blots were imaged using the FluorChem E 
system (Protein Simple) for analysis of chemiluminescent Western blots. 
Seropositivity of individual mice was determined by comparing dot blot results with 
positive and negative control sera from previous experiments and seronegative 
mice were removed from statistical analysis of the data.  
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Chapter 3 : Identification and Characterization of GRA41 
In this chapter, my aim is to identify and characterize the protein responsible 
for resistance to iiDeath in mutant MBD2.1 by sequencing the mutant to identify 
variations in the mutant genome and complementing these mutations with wild-
type copies of the genes impacted. I then endogenously tag the protein of interest 
to determine its localization and generate a complete knockout to study its impact 
on parasite function. 
Nonsense mutation in novel gene is responsible for iiDeath- phenotype of 
MBD2.1 
To identify the causative mutation in mutant strain MBD2.1, whole-genome 
sequencing was undertaken of both the mutant and its parental strain, RH∆hxgprt. 
Single nucleotide variants (SNVs) between the two were mapped against the T. 
gondii genomic database (ToxoDB). In total 18 SNVs occurred between mutant 
and parental; 5 were in intergenic regions, 11 within introns and 2 in exons. Of the 
two mutations within exons, which were both confirmed by PCR and sequencing, 
one results in a missense mutation in the hypothetical protein TGGT1_306020 and 
the other in a nonsense mutation in the hypothetical protein TGGT1_069070 
(ToxoDB v7.2). Although both transcriptomic and proteomic evidence could be 
found for TGGT1_069070 in version 7.2 of the T. gondii genomic database, this 
predicted gene has not been annotated as a gene in subsequent genome versions. 
Analysis of a cDNA library using 5’ and 3’ RACE confirmed the gene model of 
TGGT1_069070 shown in ToxoDBv7.2 (Figure 3.1, below). TGGT1_069070  
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Figure 3.1 Sequencing of TgGT1_069070 
(A) cDNA sequence with 5’ and 3’ untranslated regions (UTRs), 
which were determined by 5’ and 3’ RACE in lower case. Nucleotide 
mutated in MBD2.1 is in bold. (B) Protein sequence. Predicted 
signal sequence is underlined and phosphorylated amino acids are 
in bold, black for those phosphorylated only in intracellular parasites 
and red for those phosphorylated in both extra and intracellular 
parasites (Treeck et al 2011). Arrow indicates where protein is 
truncated in mutant MBD2.1. 
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encodes a putative 179 amino acid (aa) protein with an N-terminal signal sequence 
but no known functional domains. Though homologs of this gene are not annotated 
in any genomes present in the EuPathDB (EuPathDB.org) database, a tblastn 
search against the parasite genomes available in EuPathDB identifies potential 
homologs in the closely related parasites Hammondia hammondi 
(KL544038:723,066..723,587, 77% identity with TGGT1_069070) and Neospora 
caninum (FR823391:5,147,783..5,148,286, 47% identity). 
The nonsense mutation in TGGT1_069070 detected in the mutant strain is 
a single C to G transversion, which results in the conversion of the serine at 
position 91 to a premature stop codon (Figure 3.2, below). To investigate whether 
the mutation in this gene was responsible for the observed phenotype of MBD2.1, 
I transfected a cosmid containing a parental copy of the gene into the mutant and 
generated stable clones by limiting dilution. Two independent clones (MBD2.1 
Comp Clone 1 and MBD2.1 Comp Clone 7) were established and the incorporation 
of the parental allele was confirmed by sequencing of a PCR fragment spanning  
the TGGT1_069070 coding sequence. The sequence chromatogram from 
Clone 1 shows a mixed peak at the position of interest (Figure 3.2, below) 
indicating that this clone carries both a mutant and a parental copy of the gene as 
expected for random integration of the cosmid. On the other hand, Clone 7 
contains only the wild-type copy of the gene (Figure 3.2, below), suggesting that 
the cosmid recombined by homologous recombination with the endogenous locus  
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Figure 3.2 The iiDeath- phenotype of MBD2.1 is due to the 
introduction of a premature stop codon in TGGT1_069070. 
(A) Diagrams of the protein encoded at the TGGT1_069070 locus 
in the parental strain (top) and the putative truncated protein 
encoded in MBD2.1 as a result of the nonsense mutation in 
TGGT1_069070 (bottom) are shown. Gray rectangle represents 
predicted signal peptide and asterisks indicate relative positions of 
known phosphorylation sites (ToxoDB proteomic databases). (B) 
Chromatograms from sequencing of PCR fragment spanning 
mutated region for the parental, MBD2.1 mutant, and two MBD2.1 
clones complemented with cosmid TOXO119 (Comp clones 1 and 
7) are shown. In clone 7 the mutation has been repaired to wild 
type base indicating allelic replacement, while in clone 1 both a 
mutant and wild type allele are present as observed by mixed peak 
for base of interest (arrow). (C) Extracellular parasites of the 
parental, mutant (MBD2.1) and two complemented strains were 
exposed to 1 µM A23187 for 1 hour and allowed to form plaques 
to determine survival rate which was calculated based on survival 
of untreated parasites. Bars are average of three independent 
experiments and error bars represent standard deviation. Asterisk 
denotes statistical significance based on the results of an unpaired 
Student’s t-test with a p-value of <0.05. 
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resulting in an allelic replacement event. I have confirmed that Clone 7 still carries 
the missense mutation in TGGT1_306020 corroborating that it is indeed a 
derivative of the mutant strain MBD2.1 (data not shown). 
Importantly, regardless of whether by random integration or by allelic 
replacement, introduction of wildtype TGGT1_069070 restored ionophore 
sensitivity to MBD2.1 (Figure 3.2, above). Treatment of extracellular parasites with 
A23187 followed by plaque assay to determine number of viable parasites showed 
that, while mutant MBD2.1 has increased survivability (54%±9%, p<0.05) as 
compared to a parental strain (18%±11%), both MBD2.1 Comp Clone 1 and 
MBD2.1 Comp Clone 7, were statistically as sensitive to iiDeath as the parental 
strain (28%±5% and 26%±8% respectively, Figure 3.2, above). Thus, presence of 
a wildtype copy of TGGT1_069070 restores ionophore sensitivity to mutant 
MBD2.1. Based on this result and those described below I have focused my 
studies on the protein product of TGGT1_069070 and have not as of yet explored 
the role of the mutation found in TGGT1_306020 as it is unlikely to influence 
iiDeath. 
TGGT1_069070 encodes a novel dense granule protein, GRA41 
In order to confirm the expression of TGGT1_069070 at the protein level 
and to determine its localization, sequences encoding a carboxy-terminal (C-
terminal) triple-hemagglutinin (HA) tag were introduced into the endogenous locus 
in the RH∆ku80∆hxgprt strain just before the stop codon, using a previously 
described approach (Huynh and Carruthers 2009). Western blot analysis of protein 
extract from the endogenously tagged strain revealed a doublet migrating at 
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approximately 30 kDa, which is higher than the predicted molecular weight of the 
tagged protein, 24 KDa (Figure 3.3A, below). The doublet pattern was consistently 
observed in extracts from both intracellular and extracellular parasites (Figure 
3.3A, below). At present the reason for the migration pattern is not known, although 
the protein is predicted to be phosphorylated, which could account for size 
differences as it does for other T. gondii proteins such as GRA7 (Dunn, Ravindran 
et al. 2008). The resulting strain grows normally in culture and does not exhibit 
resistance to ionophore induced death, indicating that the tag does not interfere 
with the protein’s function (Figure 3.3B, below). To explore the localization of 
TGGT1_069070, I performed an immunofluorescence analysis (IFA) and found 
that the encoded protein appears to localize within the PV, where it colocalizes 
with the PV localized protein, GRA7 (Fischer, Stachelhaus et al. 1998, Jacobs, 
Dubremetz et al. 1998) (Figure 3.3C, below). IFA of the engineered parasites with 
antibodies against the parasite surface antigen SAG1 (Kasper, Bradley et al. 1984) 
confirmed that the majority of the HA-tagged protein is present within the PV and 
not within the parasites (Figure 3.3D, below). The majority of proteins in the PV 
are secreted by intracellular parasites from the dense granules, whose contents 
are more easily detected in extracellular parasites. To determine if 
TGGT1_069070 is also a dense granule protein, I performed an IFA of extracellular 
parasites with anti-HA antibodies to detect TGGT1_069070 and antibodies to 
dense granule marker GRA7, which shows co-localization of both signals within 
intracellular vesicles consistent with dense granules (Figure 3.3F, below). To 
confirm and refine the results from immunofluorescence analysis, I, 
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Figure 3.3 TGGT1_069070 encodes a novel dense granule 
protein, GRA41 
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along with our collaborator, Dr. Isabelle Coppins of Johns Hopkins University, 
performed immunoelectron microscopy using anti-HA antibodies to detect the 
tagged protein (Figure 3.3F, above). Within the parasite cytoplasm, the signal is 
detected predominantly within the membrane bound electron dense structures 
whose morphology and location are consistent with that of dense granules, 
confirming our observations from IFA. Within the PV the protein is exclusively 
found associated with the vesicles and tubules of the TVN and not free in the 
vacuole lumen or membrane (Figure 3.3F, above). Consistent with this 
A strain in which an 3xHA tag is expressed at the C terminus of the 
endogenous TGGT1_069070 protein was generated and analyzed 
for protein expression and localization. (A) Expression of HA 
tagged TGGT1_069070 was confirmed by Western blot in both 
intracellular and extracellular parasites. TGGT1_069070 migrates 
as a protein doublet of approximately 30 kDa (predicted molecular 
weight ~ 24 kDa). (B) Tagging of endogenous locus does not 
impact susceptibility to ionophore induced death (C-D) Intracellular 
parasites were analyzed by Immunofluorescence Assay (IFA) 
using anti-HA antibodies to detect TGGT1_069070 (in red) and 
antibodies against either the dense granule/parasitophorous 
marker GRA7 (C, in green) or the surface antigen SAG1 (D, in 
green). Scale bars, 5 µm (E) Extracellular parasites were analyzed 
by IFA using HA antibodies to detect TGGT1_069070 within the 
parasite and with antibodies against the dense granule marker 
GRA7 (in green). DAPI stain was used to detect the nucleus.  Scale 
bar, 2 µm (F) Immunoelectron microscopy was used to confirm the 
localization of TGGT1_069070, which is designated GRA41, to the 
dense granule and parasitophorous vacuole. Antibodies directed 
against HA conjugated to gold particles were used to detect 
protein. Inset in left panel is magnification of the dense granule 
marked with asterisk in image. Middle panel focuses on vacuolar 
space and shows that staining is confined to regions where 
tubulovesicular network (TVN) is present. Right panel is 
magnification of region of the middle panel where TVN is present. 
Black arrow head points at parasite membrane, white arrow head 
at parasitophorous vacuole membrane. DG= dense granule, PM = 
parasite membrane, PVM = parasitophorous vacuole membrane, 
TVN = tubulovesicular network. Scale bars, 500 nm. 
Immunoelectron microscopy analysis conducted by Isabelle 
Coppens, Johns Hopkins University. 
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membranous localization, partitioning with TX-114 showed the tagged protein 
partitions almost exclusively with the detergent phase, consistent with a 
membrane-associated protein (Figure 3.4, below). Based on these results, I have 
concluded that the protein encoded at the TGGT1_069070 locus is a dense 
granule derived protein that is secreted from the parasite into the PV where it 
associates with the TVN. According to the currently published literature, the dense 
granule proteins have been named from GRA1 to 40 so TGGT1_069070 is 
designated as GRA41. 
 
Figure 3.4 Western Blot Analysis of Triton-X 114 partitioning of 
parasite lysates from the GRA41 endogenously HA-tagged strain. 
GRA41 (detected with Rabbit anti-HA antibody) primarily partitions 
with the detergent (Det) rather than the aqueous (Aq) phase. 
ROP1 (detected with mouse anti-ROP1 antibody) was used as 
soluble protein control to label the aqueous phase and SAG1 
(detected with mouse anti-SAG1 antibody) was used as a 
membrane protein control to label the detergent phase. 
Complete knockout of GRA41 recapitulates iiDeath- phenotype 
To further study the role of GRA41 in the parasite’s life cycle, I generated a 
knockout of the gene by replacing the entire coding sequence with the selectable 
marker hypoxanthine-guanine phosphoribosyltransferase (HXGPRT) through 
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double homologous recombination into the RH∆ku80∆hxgprt strain, hereafter 
referred to as RH∆ku80 (Huynh and Carruthers 2009) (Figure 3.5A, below). 
Parasites transfected with the knockout vector (pGRA41KO) and stably expressing 
HXGPRT were selected by resistance to mycophenolic acid and xanthine and 
cloned by limiting dilution. Through two separate attempts to generate knockout 
strains, I established two independent clones (RH∆ku80∆gra41-1, aka KO1 and 
RH∆ku80∆gra41-2, aka KO2) that were shown to have correct integration of the 
construct by PCR (Figure 3.5B, below). To confirm that the genetic disruption of 
the locus resulted in a functional knockout of GRA41, I measured relative transcript 
abundance by quantitative PCR (qPCR), which failed to detect GRA41 message 
in either of the knockout clones (Figure 3.5C, below). In addition, through qPCR, I 
determined that the genetic disruption did not affect transcript levels of the genes 
immediately upstream and downstream of GRA41 (Figure 3.5C, below). Based on 
the nature of the genetic disruption expected from double recombination of the 
knockout construct (pGRA41KO, Figure 3.5A, below) and the lack of detectable 
transcript (Figure 3.5C, below), the two established clones represent functional 
knockouts and are unlikely to produce any GRA41 protein. I then assessed 
whether or not the complete knockout of GRA41 recapitulated the iiDeath- 
phenotype seen in GRA41 truncation mutant MBD 2.1. Both RH∆ku80∆gra41-1 
(45% ± 16% versus 11% ± 12% for the parental strain, p<0.05, Figure 3.5D, below) 
and RH∆ku80∆gra41-2 (25% ± 5% versus 7% ± 5% for the parental strain, p<0.05, 
Figure 3.5D, below) showed statistically significant increases in survival as 
compared to the parental strain after 60 minutes of treatment with A23187. Thus, 
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the recapitulation of the phenotype seen in the mutant MBD2.1 by the complete 
lack of GRA41 suggests that the iiDeath phenotype of MBD2.1 is likely due to the 
absence of full-length GRA41 product and not a dominant negative effect imparted 
by a possible truncated protein. 
 
Figure 3.5 Complete knockout of GRA41 recapitulates the iiDeath- 
phenotype seen in MBD2.1 mutant.  
(A) Diagram shows strategy used to knockout GRA41 by double 
homologous recombination replacing the GRA41 locus with the 
HXGPRT selectable marker. Colored arrow heads indicate 
beginning and end of genomic regions used to drive homologous 
recombination of pGRA41KO vector with target locus in 
chromosome X (ChrX). Arrows indicate relative direction of 
transcription of the three genes depicted and black arrow heads 
represent primers p1, 2 and 3 used to corroborate integration. (B) 
PCR analysis of DNA from parental strain (Par) and two 
independent putative knockouts KO1 (top panels) and KO2 
(bottom panels) using either a primer pair expected to produce an 
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Complete knockout of GRA41 results in decreased plaquing efficiency 
While performing the iiDeath assays described above I noted that, although 
the same number of untreated parasites were used for all strains, the knockout 
parasites consistently established fewer plaques (discrete areas of host cell 
distruction resulting from the invasion of a single parasite followed by multiple lytic 
cycles) as compared to the parental. To determine whether the knockout strains 
truly had reduced plaquing efficiency, which would suggest a defect in the lytic 
cycle of the parasite, I infected cells with an equal number of freshly harvested, 
untreated parasites of the parental and knockout strains and allowed them to 
invade for two hours before removing extracellular parasites. Intracellular parasites 
were allowed to form plaques, which were quantitated on the sixth day post 
infection. Both clones showed a statistically significant decrease in the number of 
plaques as compared to the parental without any noticeable differences in plaque 
size (18%±12% of parental efficiency for RH∆ku80∆gra41-1, 63%±9% for 
RH∆ku80∆gra41-2, p<0.05), although the phenotype of the second independently 
generated clone was attenuated compared to the first (Figure 3.6A, below). 
amplicon in both parental and knock strains (p1-p2, left panels) or 
a test primer pair that would produce a product only if the GRA41 
gene were replaced (p2-p3, right panels). (C) qPCR analysis was 
used to monitor transcript levels of GRA41 and the two flanking 
genes TGGT1_236870 and TGGT1_236860 in the parental (Par) 
and two knockout strains (KO1 and KO2). Data is expressed as 
∆∆Ct of each relative to that of parental and represents average of 
3 independent experiments (D) Extracellular parasites of the 
parental and KO1 (left) and KO2 (right) mutant (MBD2.1 were 
exposed to 1 µM A23187 for 45 or 60 minutes and survival rate 
was determined as in Fig. 1. Bars are average of three 
independent experiments and error bars represent standard 
deviation. Asterisk denotes statistical significance based on the 
results of an unpaired Student’s t-test with a p-value of <0.05. 
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Consistent with this apparently variable phenotype, I observed that continuous 
passage of the RH∆ku80∆gra41-1 in in vitro culture results in a relative loss of 
phenotype over the course of a few weeks. Plaque assays conducted over the 
course of two weeks showed the gradual increase in plaquing efficiency from 11% 
to 56% for clone RH∆ku80∆gra41-1 (Figure 3.6B, below). Continued passage of 
adapted parasites in culture resulted in a strain that grows robustly, exhibiting more 
and larger-sized plaques as compared to the parental strain (data not shown). 
Thus, the loss of GRA41 resulted in reduced plaquing efficiency of tachyzoites, 
and the parasites adapted to this phenotype during continuous passage in culture, 
suggesting a defect in one or more steps of the lytic cycle that is either lost or 
compensated for over time. 
Complementation of GRA41 knockout with the parental gene rescues both 
iiDeath sensitivity and lytic cycle defects 
While the fact that two independent knockout strains exhibited the same 
plaquing phenotype support the idea that the lack of GRA41 affects parasite 
propagation, there is always the possibility that secondary mutations are 
responsible for the observed phenotype. The introduction of a wild-type allele of 
GRA41, as was done for MBD2.1, would address this issue. However, the rapidity 
with which this strain adapts to in vitro culture would complicate the interpretation 
of phenotypic complementation, and a return to wild type levels of plaquing by a 
complemented strain could be due to either the addition of the wild type allele or 
simply to adaptation during the complementation process, which can take several  
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Figure 3.6 Complete knockout of GRA41 results in reduced 
plaquing efficiency which is rescued by complementation. 
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(A) Extracellular parasites of the parental and knockout strains 
were allowed to form plaques to assess plaquing efficiency, which 
was calculated by dividing the number of plaques formed for each 
knockout strain by that formed by the parental strain. (B) 
Extracellular parasites of RH∆ku80∆gra41-1, which had been 
maintained in culture for different amounts of time, were allowed to 
form plaques as in (A) to determine if knockout parasites were able 
to adapt to loss of GRA41 in respect to plaquing efficiency. (C) 
Diagram (left) shows the strategy for complementation of gra41 
knockout by double homologous recombination of cosmid 
TOXO119 into the target locus. Parasites transformed with cosmid 
were exposed to 6-thioxanthine to select for loss of the HXGPRT 
cassette. Flow chart (right) shows the isolation of resulting clones. 
Indicated below each clone is the relative transcript level of gra41 
(as described in Figure 3) and the presence/absence of the 
HXGPRT cassette, which was determined by sensitivity to MPA. 
(D) Extracellular parasites of the parental, knockout and 
complemented clones were allowed to grow for twenty-four hours 
before fixing and counting the number of vacuoles per field of view 
(vacuole formation). Bars are average of three independent 
experiments and errors bars represent standard deviation. Asterisk 
denotes statistical significance based on the results of an unpaired 
Student’s t-test with a p-value of <0.05. 
weeks. Thus, a complementation strategy was devised that could control for 
adaptation based on repairing the disrupted GRA41 locus by homologous 
recombination using the same cosmid utilized to complement mutant MBD2.1 
(Figure 3.6C, above). This approach took advantage of the fact that the HXGPRT 
marker, which was used to replace GRA41 in the knockout strains (Figure 3.5A, 
above), can be selected against with 6-thioxanthine (Donald, Carter et al. 1996). 
Because 6-thioxanthine’s effect is static and not cidal (Pfefferkorn, Bzik et al. 2001) 
I was able to transfect the knockout strain with the cosmid containing GRA41, 
select for lack of HXGPRT for 2 weeks, clone by limiting dilution and obtain two 
types of randomly selected clones: those with detectable levels of GRA41 
transcript by qPCR and still HXGPRT+ as demonstrated by resistance to MPA/XAN 
treatment (∆gra41A and B in Figure 3.6C, above), and those with measurable 
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levels of GRA41 transcript and now HXGPRT- (∆gra41C and D in Figure 3.6C, 
above). Since all clones, both the ones with GRA41 and those without, had gone 
through the same manipulations and been in culture for the same amount of time, 
direct comparison of phenotypes could be performed with some control over 
possible adaptation. Though the knockout strain also differs from the parental and 
the complemented strain by the presence of HXGPRT, previous work has shown 
that the loss of HXGPRT does not play a role in iiEgress, iiDeath or parasite 
propagation (Arrizabalaga, Ruiz et al. 2004), supporting the conclusion that any 
differences seen are due to the loss of GRA41. The ability of these parasites to 
grow efficiently in in vitro culture was assessed by allowing parasites to infect a 
confluent monolayer of host cells for two hours, then allowing them to grow for an 
additional 22 hours before fixing them and counting the number of vacuoles per 
field of view. The number of vacuoles formed by the KO clones over that by the 
parental strain was used to convey the relative efficiency of vacuole formation. 
While both clones still lacking GRA41 (∆gra41a and ∆gra41b) showed a 
significantly decreased frequency of vacuole formation (49%±7% and 50%±33% 
respectively, p<0.05), the two clones in which GRA41 expression was restored 
(∆gra41c and ∆gra41d) had significantly enhanced ability to establish vacuoles 
(125%±20% and 121%±37% respectively, Figure 3.6D, above). Thus, GRA41 
plays a role in the efficiency of the parasite’s propagation cycle in addition to 
sensitivity to iiDeath treatment. 
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Complete knockout of GRA41 affects timing of natural egress 
To better define the phenotype of GRA41 loss of function I probed the ability 
of RH∆ku80∆gra41-1 to complete the various steps of the lytic cycle. I first 
performed a 30 minute post-invasion assay as described previously (Carruthers, 
Giddings et al. 1999) to measure the parasite’s ability to attach and invade host 
cells. A slight but statistically significant reduction in the percentage of invaded 
parasites was seen from 63%±5% in the parental strain to 45%±11% in 
RHΔku80Δgra41-1, though no difference was seen in attachment efficiency of the 
GRA41 knockout strain (Figure 3.7, below). Thus, loss of GRA41 leads to a small  
reduction in invasion efficiency. Since the level of reduction in invasion efficiency 
is not sufficient to explain the 50 to 80% reduction plaquing efficiency, I looked at 
post-invasion lytic cycle steps to determine why parasites were inefficient in 
forming plaques after successful initial invasion. From the vacuole formation assay 
used to assess successful complementation, it was apparent that there was a 
decrease in the number of vacuoles present as early as 24 hours post-infection, 
so I chose to see what was occurring before and after this time point during  
 
Figure 3.7  Complete knockout of GRA41 results in decreased 
invasion efficiency 
(A) Attachment efficiency of RH∆Ku80∆GRA41 strain relative to 
parental (B) Percent of total parasites present in culture that 
successfully invaded. Average of three independent replicates. 
Error bars represent standard deviation. *, p<0.05 
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Figure 3.8 Complete knockout of GRA41 leads to premature 
egress of parasites. 
(A) Extracellular parasites of the parental, knockout and 
complemented strains were allowed to invade for two hours before 
removing parasites that remained outside. Invaded parasites were 
allowed to grow for a total of 12, 24 or 30 hours before fixing and 
counting the number of parasites per vacuole for a minimum of 100 
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vacuoles per strain. (B) The average number of parasites per 
vacuole for the data in (A) was calculated for each strain and 
graphed as a function of time. (C) The average number of vacuoles 
per field of view for the data in (A) was calculated for each 
strain/time point and normalized to the twelve-hour time point. (D) 
Percentage egress was calculated for each strain following 5, 10 
or 20 minute treatment with 5 mM DTT. All data is the average of 
at least three independent experiments and errors bars represent 
standard deviation. Asterisk denotes statistical significance based 
on the results of an unpaired Student’s t-test with a p-value of 
<0.05. 
parasite replication. Intracellular parasites from the parental, knockout and 
complemented strains were manually extracted from host cells, harvested, 
counted and allowed to invade confluent HFFs in multiple twenty-four well plates 
for two hours. Each plate was fixed at twelve, twenty-four or thirty hours post-
infection and the number of parasites per vacuoles were determined for at least 
100 vacuoles per sample (Figure 3.8, above). No statistically significant difference 
in the average number of parasites per vacuole was seen at twelve or twenty-four 
hours, suggesting that the knockout parasites were replicating at a normal rate 
(Figure 3.8A and B, above). However, the knockout parasites showed a more than 
two-fold decrease in the average number of parasites per vacuole at thirty hours 
post infection (from 15±1 parasites/vacuole for parental to 4±0.3 parasites/vacuole 
for knockout, p < 0.001, Figure 3.8B, above), while the complemented strain is not 
significantly different from the parental (14±3 parasites/vacuole, p>0.05). This 
decrease in the average number of parasite per vacuole from 24 to 30 hours post 
infection for the knockout strain is due to a decrease in the proportion of large 
vacuoles, which coincides with an increase in the number of vacuoles containing 
1-2 parasites (Figure 3.8A, above). This pattern (i.e. decrease in large vacuoles 
and increase in small ones) is consistent with egress and reinvasion, and suggests 
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that natural egress for the GRA41 knockout strain is occurring between 24 and 30 
hours. This contrasts with what is observed with both the parental and 
complemented parasite strain, which continue to divide within the original vacuoles 
between 24 and 30 hours (Figure 3.8A, above).  
In addition to quantifying the average number of parasites per vacuole, the 
average number of vacuoles per field of view was also assessed for each strain to 
see if vacuoles were being lost (due to egress without reinvasion or death) or 
gained (due to egress with reinvasion). The average number of vacuoles per field 
of view for both the parental and the complemented strains stayed relatively 
constant overtime, while the knockout parasites first appeared to lose vacuoles 
between 12 and 24 hours post infection (48±13% of the vacuoles twelve hours, 
p<0.05, Figure 3.8C, above) and then gain vacuoles between 24 and 30 hours 
post infection (195±48% of the vacuoles at twelve hours, p<0.05, Figure 3.8C, 
above). The reduction in number of vacuoles between 12 and 24 hours post 
infection is consistent with our previous data looking at parasites either shortly after 
invasion or at twenty-four hours after infection. When looking shortly after invasion, 
there was only a modest decrease in invasion efficiency for the knockout parasites 
(Figure 3.7, above). However, there is a pronounced difference in the number of 
vacuoles present at 24 hours between the strains, which would be explained by 
losing vacuoles between 12 and 24 hours (Figure 3.6D, above). In conjunction, 
these results are consistent with an early egress phenotype in the knockout 
parasites, with the parasites egressing between 12 and 24 hours failing to reinvade 
and the parasites egressing between 24 and 30 hours reinvading successfully. 
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Thus, analysis of the lytic cycle indicates that the loss of GRA41 does not impact 
division rate of the parasites, but does lead to early egress of parasites, which 
would account for a majority of the decrease in plaquing efficiency reported above. 
Interestingly, the original MBD2.1 mutant (Black, Arrizabalaga et al. 2000) 
as well as the GRA41 knockout strain (data not shown) appear to also undergo 
egress at a faster rate than their parental strain after induction with the ionophore 
A23187. Nonetheless, because of the high efficiency and fast rate of iiEgress the 
effect is very slight and difficult to statistically validate. Accordingly, I tested the 
sensitivity of the GRA41 knockout to a different inducer of egress, the redox 
reagent DTT, which typically requires that parasites be infected for approximately 
36 hours before induction and induces egress with slower kinetics than A23187 
(Stommel, Cho et al. 2001). For this purpose, parasites were allowed to infect host 
cells for 24 hours before inducing egress with 5 mM DTT. The GRA41 knockout 
strain does show evidence of significant enhanced egress as compared to the wild-
type and complemented strains at both 10 and 20 minutes post-induction 
(62%±19% versus 2±2% and 15±13% at 10 minutes, 85%±14% versus 5%±9% 
and 14%±13% at 20 minutes, Figure 3.8D, above, p<0.05), indicating that the 
GRA41 knockout strain is sensitive to induction of egress by DTT earlier in the 
replication phase of the lytic cycle as compared to the parental and complemented 
strains. 
  
 75 
Chapter 4 : Functional Analysis of GRA41 
In Chapter 3, I identified the novel dense granule protein, GRA41, as the 
protein responsible for the resistance to iiDeath in mutant MBD2.1. In this chapter, 
I aim to elucidate the mechanisms by which GRA41 might be impacting calcium 
homeostasis by testing calcium levels in the parasite, calcium binding in the 
recombinant GRA41 protein, identifying GRA41 interactors and looking for 
additional phenotypes that could explain the resistance to iiDeath. 
Ionophore induced death is due to decreased attachment and decreased 
stimulated microneme secretion 
To determine the exact reason why parasites exposed to ionophore for 
extended periods of time were unable to form plaques in host cells, an ionophore 
treatment of parental (RH∆hxgprt) parasites was conducted followed by an 
invasion assay. Since the two distinct processes of attachment and invasion are 
both required for successful entry into a host cell, it was necessary to distinguish 
which step the ionophore affected. The invasion assay distinguishes between 
attached and invaded parasites after a short incubation time by selective labeling 
the parasite surface with antibodies. First, the attached parasites are labeled with 
antibody directed to a parasite surface antigen without any permeabilization step 
that would allow the antibody to cross the host cell membrane. The antibody is 
then washed away before the host cell membrane is permeabilized and all 
parasites are labeled with an additional antibody, which can be directed to any part 
of the parasite. Attached parasites are labeled with both antibodies, which can be 
detected with fluorophore-conjugated secondary antibodies, while invaded 
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parasites are only labeled with a single antibody. An invasion assay performed 
after extracellular treatment of the parasites with 1 μM A23187 for one hour 
showed that while ionophore-treated parasites showed no defect in invasion (data 
not shown), they were severely affected in their ability to invade. Compared to 
DMSO solvent control-treated parasites, ionophore treated parasites exhibited 
nearly a 70% decrease in the number of attached parasites, indicating that 
prolonged ionophore treatment leads to a defect in host cell attachment (Figure 
4.1A, below). Since attachment has been shown to be mediated by secretion of 
proteins from the micronemes, which can be stimulated by treatment with 
ionophore, a micronemal secretion assay was conducted to verify that the defect 
in attachment was due to a defect in micronemal secretion (Wan, Carruthers et al. 
1997, Carruthers and Sibley 1999). To do this, extracellular parental (RH∆hxgprt) 
parasites were exposed to ionophore or DMSO control for one hour before 
separating parasites from secreted proteins by centrifugation. Both the DMSO and 
ionophore pellets were then divided in half and subjected to an additional treatment 
with either DMSO or ionophore. Subsequent supernatants and pellets were then 
separated by SDS-PAGE followed by Western Blot in order to visualize 
micronemal protein MIC2. As expected, the initial treatment with ionophore 
resulted in increased micronemal secretion as compared to the DMSO control 
(Figure 4.1B, below). For the parasites subjected to a one hour DMSO treatment, 
similar results were seen, with ionophore treated parasites showing increased 
secretion compared to the DMSO treated controls. However, the parasites that had 
first undergone the ionophore induced death treatment showed no difference in 
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secretion when treated with ionophore as compared to the DMSO control, showing 
that secretion of MIC2 is no longer enhanced in response to the induction of 
calcium fluxes. The resulting pellets from the ionophore induced death treated 
parasites were also included to show that there is still MIC2 remaining inside the  
 
 
Figure 4.1 Ionophore treatment of extracellular parasites causes a 
decrease in host cell attachment and microneme secretion. 
(A) RH∆hxgprt parasites treated with 1 μM ionophore A23187 
show decreased ability to attach to host cells as compared to 
DMSO treated control parasites. (B) Western Blot analysis of MIC2 
secretion after extracellular treatment of parasites with either 
DMSO or 1 μM A23187 for one hour. Supernatants containing 
secreted proteins were separated by centrifugation before 
submitting parasites to a second treatment with either DMSO or 1 
μM A23187. Micronemal secretion was assessed by Western blot 
analysis of the supernatants using a mouse monoclonal antibody 
directed against MIC2 (Wan et al, 1997). 
parasite. Defining the consequences of iiDeath treatment on wild-type parasites 
can help to clarify the phenotype by which the GRA41 mutant, MBD2.1, was 
originally isolated. Though A23187 is capable of transporting calcium, it can also 
transport other divalent cations. These divalent cations are exchanged for protons, 
meaning this process is also pH-dependent (Reed and Lardy 1972). Here, I have 
shown that the iiDeath treatment results in parasite death as a result of decreased 
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attachment and micronemal secretion. Since micronemal secretion (and 
subsequently attachment) is triggered by a calcium increase in the parasite 
cytosol, these results suggest that the iDeath phenomenon is a result of A23187’s 
ability to transport calcium, rather than changes in pH or the transport of a different 
divalent cation. This supports the hypothesis that GRA41 could be impacting 
parasite sensitivity to iiDeath by a calcium-dependent mechanism. 
Complete knockout of GRA41 leads to dysregulation of parasite calcium  
Because GRA41 was initially identified as a result of a forward genetic 
screen involving altered sensitivity to treatment with calcium ionophore, and its 
complete knockout led to defects in events known to depend on calcium 
homeostasis and fluxes, I wanted to compare free cytosolic calcium levels in 
knockout and complemented strains with the parental (Figure 4.2, below). For this 
purpose, we collaborated with Silvia Moreno’s laboratory at the University of 
Georgia; all calcium experiments were conducted by a graduate student of Dr. 
Moreno’s, Karla Marquez-Nogueras. To measure free cytosolic calcium within the 
parasites, extracellular parasites of the parental, GRA41 knockout and 
complemented strains were loaded with fluorescent calcium indicator Fura-2 and 
fluorescence measurements were made before and after adding calcium to the 
suspension buffer. Compared to the parental strain, the knockout has elevated 
cytosolic calcium under calcium-free buffer conditions, which is not rescued by 
complementation with wild-type GRA41 (Figure 4.2, below). This suggests that the 
elevated free cytosolic calcium might not be a direct consequence of the loss of 
GRA41. Instead it could be either part of the way the parasites adapt to its loss or 
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Figure 4.2 GRA41 knockout parasites exhibit enhanced uptake of 
extracellular calcium. 
Extracellular parasites from the parental, knockout and 
complemented strains were loaded with Fura-2 AM to monitor 
calcium levels. The arrows represent the time at which 1 mM Ca2+ 
was spiked in to the medium. Increase in calcium levels after 
addition of extracellular calcium over basal levels was quantitated 
for at least three independent replicates, trace shown is the 
average of three independent experiments. Error bars represent 
standard deviation. Asterisk denotes statistical significance based 
on the results of an unpaired Student’s t-test with a p-value of 
<0.05, double asterisks denotes p value of <0.01. Calcium 
measurements conducted by Karla Marquez-Noguera, Moreno 
Laboratory, University of Georgia. 
an unrelated event. However, when the ability of parasites to uptake extracellular 
calcium was measured by adding 1mM CaCl2 to the buffer, the knockout strain 
showed a 2.45-fold increase in uptake of extracellular calcium over both the 
parental and complemented strains (Figure 4.2, above, p<0.05). Thus, these 
results suggest that the loss of GRA41 leads to a dysregulation of parasite calcium, 
which likely has wide-reaching impacts on calcium-dependent events in the lytic 
cycle. 
Complete knockout of GRA41 disrupts vacuolar morphology 
During the lytic cycle analysis described in Aim 1 Results, consistent 
differences in the organization of parasites within the vacuole and the gross 
morphology of the vacuole membrane between the knockout and parental strain 
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were seen, suggesting a role of GRA41 to maintain normal vacuolar morphology. 
To investigate the possibility that the loss of GRA41 disrupted vacuolar 
morphology, I visualized the parasites under high power magnification and noted 
that many of the vacuoles in the knockout strain appeared to be collapsed around 
the parasites within (Figure 4.3A, below). Quantitation of this “collapsed vacuole” 
phenotype showed it was significantly more common in the GRA41 knockout strain 
as compared to the parental and complemented strains (43±1% versus 10±6% 
and 10±4%, respectively, p<0.05, Figure 4.3B, below). Furthermore, I noted that 
the vacuoles in the knockout strain were more likely to have atypical numbers of 
parasites. Typically, all parasites within the vacuole divide simultaneously into two 
daughter parasites leading to a doubling of parasite number and a geometric 
sequence of parasite number within each vacuole (i.e. 2, 4, 8, 16, etc.). 
Nonetheless, 35±2% of the knockout vacuoles contained a number of parasites 
that did not follow the normal pattern. This was significantly higher than both the 
parental and complemented strains, with 12±3% and 7±2% respectively (Figure 
4.3C, below, p<0.05). To investigate how this might be occurring, both parental 
and GRA41 knockout parasites were stained for acetyl tubulin. The acetylation of 
tubulin occurs during parasite replication and can be used to visualize the daughter 
parasites as they are dividing (Varberg, Padgett et al. 2016). Using this method, I 
was able to image GRA41 knockout parasites that showed evidence of more than 
two daughters forming per mother parasites, which would explain the abnormal 
number of parasites in some vacuoles (Figure 4.3D, below). The formation of 
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Figure 4.3 GRA41 knockout parasites have altered vacuole 
morphology and division pattern. 
 (A) Intracellular parasites of the parental, knockout and 
complemented strains were fixed and imaged at 24 hours post 
infection. White arrowheads indicate the collapsed appearance of 
a vacuole around the parasites in parasites of the knockout strain. 
(B) Vacuoles from the parental, knockout and complemented 
strains containing four parasites each were assessed for the 
“collapsed vacuole” phenotype. Bars are average of three 
independent experiments and errors bars represent standard 
deviation. Asterisk denotes statistical significance based on the 
results of an unpaired Student’s t-test with a p-value of <0.05. (C) 
Vacuoles from the parental, knockout and complemented strains 
were fixed at twenty-four hours post infection. Vacuoles with an 
abnormal number of parasites (i.e. not 2, 4, 8 or 16) were quantified 
for each strain. Bars are average of three independent 
experiments and errors bars represent standard deviation. Asterisk 
denotes statistical significance based on the results of an unpaired 
Student’s t-test with a p-value of <0.05. (D) Intracellular parasites 
of the parental and knockout strains were stained with an antibody 
against acetylated tubulin to visualize dividing parasites. Arrows 
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show three daughter parasites for a single mother parasite in the 
knockout strain. 
triplet and even quadruplet parasites has been observed in wild-type parasites at 
low levels (Hu, Mann et al. 2002), suggesting that the knockout of GRA41 has 
increased the frequency with which this happens. 
Complete knockout of GRA41 leads to altered structure of the tubulovesicular 
network  
The “collapsed vacuole” and abnormal cell division are both similar to the 
abnormal vacuole morphology and parasite organization associated with the 
genetic disruption of GRA2, another secreted protein that localizes to the TVN and 
that is critical for its formation (Mercier, Dubremetz et al. 2002). Accordingly, I 
examined the structure of the TVN in the GRA41 knockout strain by transmission 
electron microscopy (Figure 4.4, below). Host cells were infected with freshly 
egressed tachyzoites for twenty-four hours prior to fixing and preparing samples 
for thin sectioning. Thin sectioning and imaging were done with the assistance of 
Dr. Barry Stein of the Indiana University-Bloomington Electron Microscopy Core 
Facility. The parental, knockout and complemented strains all showed normal 
morphology of the PV membrane, but the knockout strain appeared to have fewer 
tubules within its network and an increase in the small vesicles from which the 
tubules form (Figure 4.4, below). Additionally, the tubules that do form in the TVN 
of the knockout strain appeared to be shorter than those of the parental and 
complemented strains (Figure 4.4, below). Since the GRA41 knockout showed 
similar disruption of the tubulovesicular network with the GRA41 knockout, I tested  
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Figure 4.4 GRA41 knockout parasites show altered morphology 
and size of tubulovesicular network (TVN) as compared to the 
parental and complemented strains 
Intracellular parasites were fixed at 24 hours post infection and 
prepared for imaging. Red arrowheads in left panels point at 
regions were imaged at higher magnification in the respective right 
panels. 
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to determine whether the GRA2 knockout (parental, knockout and complemented 
strains graciously provided by Dr. Vern Carruthers, University of Michigan) would 
mirror the resistance to iiDeath treatment of the GRA41 knockout. In contrast to 
the GRA41 knockout, the GRA2 knockout did not show any increased survival over 
its parental and complemented strains at either 45 or 60 minutes of treatment 
(32±10% versus 26±4% and 30±13% at 45 minutes, respectively and 17±17% 
versus 12±7% and 18±14% at 60 minutes, respectively, p>0.05, Figure 4.5, 
below), suggesting that this phenomenon is restricted to the disruption of GRA41 
and not a general feature of parasites with disrupted tubulovesicular networks. 
 
Figure 4.5 Ionophore induced death phenotype of Gra2 parental, 
knockout and complemented strains. 
Percent survival of parasites treated with 1 μM A23187 versus 
DMSO solvent control for 45 or 60 minutes. Average of three 
independent replicates. Error bars represent standard deviation. 
Incubation of recombinant GRA41 with calcium does not affect protein melting 
temperature 
To address question of whether GRA41 binds calcium and impacts calcium 
homeostasis in this way, I isolated recombinant Histidine-tagged TgGRA41 from 
transfected E. coli cells with the assistance of Dr. Sanofar Abdeen (Johnson 
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Laboratory, Indiana University School of Medicine). Purified GRA41 was incubated 
with varying concentrations of CaCl2 and subjected to a melt curve analysis using 
SYPRO Orange Dye. This technique, termed differential scanning fluorimetry, 
utilizes the capability of SYPRO orange dye to bind to the unfolded hydrophobic 
regions of denatured proteins. Once bound, the SYPRO orange dye will fluoresce; 
the intensity of this fluorescence is directly related to the portion of the protein that 
is unfolded. In this way, the samples can be subjected to a melt curve analysis 
using a real-time PCR machine and melting temperatures can be calculated. The 
addition of a ligand to the protein/dye combination will shift the melting  
 
Figure 4.6 Melt curve analysis of GRA41 recombinant protein 
incubated with calcium 
When recombinant GRA41 is incubated with varying 
concentrations of CaCl2 there is no apparent difference in the 
melting temperature of protein incubated in the presence of 
calcium. The Calcium-Dependent Kinase 3 (CDPK3), shows an 
inverse relationship between calcium concentration and melting 
temperature. 
temperature, with increasing amounts of ligand causing increasingly larger shifts 
(Niesen, Berglund et al. 2007). In contrast to recombinant CDPK3, which contains 
calcium binding EF hand domains, GRA41 does not show any change in melting 
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temperature when calcium is added to the sample, suggesting that the 
recombinant protein is not capable of binding calcium. Though this doesnot rule 
out the possibility that GRA41 is capable of binding calcium under certain 
circumstances, it suggests that it is does not form a strong interaction with calcium 
at the concentrations tested that is detectable using this assay. 
Attempts to identify interactors of GRA41 by immunoprecipitation yield 
inconsistent results 
To begin to understand the mechanisms by which GRA41 might be 
functioning, I performed a traditional co-immunoprecipitation using the Type I 
endogenously HA-tagged strain to identify potential protein interaction partners. 
Due to its location in the parasitophorous vacuole, intracellular parasites were 
harvested along with the host cells and parasitophorous vacuoles by scraping and  
Gene ID 
(ToxoDB.org) 
Product Description 
(ToxoDB.org) 
Computed Gene 
Ontology Function 
(ToxoDB.org) 
Expect 
Value 
TGME49_227280 dense granule protein GRA3 None 
2.70E-
05 
TGME49_217460 glutaminyl-tRNA synthetase (GlnRS) 
ATP binding, 
glutamine-tRNA ligase 
activity 
1.80E-
04 
TGME49_219540 tRNA-Ala synthetase 
ATP binding, alanine-
tRNA ligase activity, 
nucleic acid binding 
2.40E-
04 
TGME49_299810 cysteine-tRNA synthetase (CysRS) 
ATP binding, cysteine-
tRNA ligase activity 
2.40E-
04 
TGME49_233460 SAG-related sequence SRS29B None 
2.70E-
04 
TGME49_291960 
rhoptry kinase 
family protein 
ROP40 (incomplete 
catalytic triad) 
transferase activity, 
transferring 
phosphorus-containing 
groups 
5.70E-
04 
TGME49_236210 
peptidase M16 
family potein, 
putative 
catalytic activity, metal 
ion binding, 
metalloendopeptidase 
6.20E-
04 
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activity, zinc ion 
binding 
TGME49_233480 SAG-related sequence SRS29C None 
6.60E-
04 
TGME49_251500 
eukaryotic initiation 
factor-3, subunit 3, 
putative 
protein binding 9.30E-04 
TGME49_308090 rhoptry protein ROP5 
ATP binding, protein 
kinase activity 0.001 
TGME49_309730 thioredoxin reductase 
NADP binding, flavin 
adenine dinucleotide 
binding, glutathione-
disulfide reductase 
activity, thioredoxin-
disulfide reductase 
activity 
0.001 
TGME49_219550 
dihydrolipoyllysine-
residue 
succinyltransferase 
component of 
oxoglutarate 
dehydrogenase 
dihydrolipoyllysine-
residue 
succinyltransferase 
activity 
0.0011 
TGME49_290700 hypothetical protein None 0.0014 
TGME49_319340 hypothetical protein None 0.0015 
TGME49_295110 rhoptry protein ROP7 
ATP binding, protein 
kinase activity 0.0017 
TGME49_251540 dense granule protein GRA9 None 0.002 
TGME49_309590 rhoptry protein ROP1 None 0.0051 
TGME49_279100 hypothetical protein None 0.016 
TGME49_297650 
Ser/Thr 
phosphatase family 
protein 
acid phosphatase 
activity, hydrolase 
activity 
0.02 
TGME49_226380 hypothetical protein None 0.022 
TGME49_215775 rhoptry protein ROP8 
ATP binding, protein 
kinase activity 0.027 
resuspending in lysis buffer. The samples were further solubilized by sonication 
before the lysates were incubated with anti-HA antibody. After the antibody was 
allowed to bind to the GRA41 HA epitope tag, the entire antibody/antigen complex 
Table 4.1 Proteins identified following immunoprecipitation of GRA41 
from whole cell lysates 
Proteins are ranked by expect value, from smallest to largest. 
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was pulled out of the lysate using Protein G-coupled dynabeads, which bind to the 
anti-HA antibody. The beads were washed and the contents eluted in sample 
buffer before performing an SDS-PAGE separation and silver stain of the resultant 
gel. After successful detection of bands at the correct molecular weight for the 
GRA41 doublet observed by Western Blot analysis, three regions with significant 
silver staining were excised and sent to the Indiana University Bloomington Mass 
Spectrometry core facility for protein identification. The resulting protein list was 
restricted to proteins not found in unrelated pulldowns (LaFavers and Arrizabalaga, 
unpublished data), those which contained a signal peptide and those which had 
an expect value of <0.0025. These proteins are listed from most to least likely in 
Table 4.1, above. Of these proteins, only two are known dense granule proteins, 
GRA3 and GRA9. Of the remaining proteins, five are known rhoptry proteins and 
two are surface antigens. The remaining proteins are a mixture of proteins of 
hypothetical function and uncharacterized proteins that have conserved functional 
domains, such as a putative gluatminyl-tRNA synthetase. Additional efforts to 
repeat these results were met with little success, as mass spectrometry analysis 
of both prior and subsequent GRA41 pulldowns with samples submitted on 
magnetic beads failed to identify GRA41 as a hit in the data analysis and were 
disregarded. Due to these difficulties, a yeast two-hybrid approach was taken to 
identify GRA41 candidate interactors. 
GRA41 has several high confidence interactions in yeast two hybrid screen 
A yeast two hybrid screen was conducted by Hybrigenics Services using 
the GRA41 sequence with the signal peptide removed as a protein bait. Resulting 
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interactors were scored for statistical significance and ranked according to 
expected values that take into account results from the GRA41 screen along with 
all other screens against the T. gondii prey library. They are then assigned a global 
predictive biological score from A (interactions with very high confidence) to F 
(experimentally proven technical artifacts). Included in the table below are prey 
proteins with a score of A, B (high confidence) and C (good confidence). Prey with 
scores of D (moderate conference), E (interactions involving highly connected prey 
domains, likely non-specific), and F were not included. Also removed were 
common hits from unrelated nuclear proteins used as bait by the Sullivan 
laboratory and an unrelated mitochondrial protein used as bait by the Arrizabalaga 
lab against the same database (Garbuz, Harris, Huang, Srivasta, Arrizabalaga, 
and Sullivan, unpublished data). The remaining hits included 11 proteins, three 
ToxoDB.org 
Gene ID 
Glob
al 
PBS 
Product 
Description 
(ToxoDB.or
g) 
Signal 
Peptid
e 
# TM 
Domain
s 
Predicted 
Localization (psort) 
TGME49_2708
00 A 
GAF 
domain-
containing 
protein 
Yes 0 Nuclear/mitochondrial 
TGME49_2026
80 A 
peptidase 
M16, alpha 
subunit, 
putative 
Yes 0 Mitochondrial 
TGME49_2023
70 A 
T-complex 
protein 1, 
epsilon 
subunit 
(TCP-1-
epsilon), 
putative 
No 0 N/A 
TGME49_2702
50 B 
dense 
granule Yes 0 Extracellular 
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protein 
GRA1 
TGME49_2517
80 B 
heat shock 
protein Yes 0 Mitochondrial 
TGME49_2204
80 B 
hypothetical 
protein Yes 0 
Nuclear, plasma 
membrane or 
extracellular 
TGME49_2236
80 B 
ubiquitin 
family 
protein 
No 0 N/A 
TGME49_2334
90 C 
hypothetical 
protein No 0 N/A 
TGME49_2858
30 C 
hypothetical 
protein No 2 N/A 
TGME49_2441
10 C 
nucleosome 
assembly 
protein 
(nap) 
protein 
No 0 N/A 
TGME49_3063
50 C 
variable 
surface 
lipoprotein 
No 0 N/A 
with a score of A, and four each with scores of B and C (Table 4.2, above). Of 
these, five have predicted signal peptides, suggesting they could be secreted into 
the parasitophorous vacuole with GRA41. One of the proteins with a signal peptide 
is the founding member of the dense granule family, GRA1, which is a highly 
abundant protein secreted into the parasitophorous vacuole. Interestingly, GRA1 
has been shown to be capable of binding calcium in vitro, though the exact function 
of this protein is unknown due to the lack of a published knockout (Cesbron-
Delauw, Guy et al. 1989). Of the remaining hits containing signal peptides, only 
one is predicted to be potentially secreted according to Psort, a protein of 
Table 4.2 GRA41 Potential Interactors from Yeast Two Hybrid 
Analysis 
Proteins are ranked by global predictive biological score (PBS) from 
highest confidence interactions to lowest confidence interactions. TM 
= transmembrane Yeast Two Hybrid Analysis conducted by 
Hybrigenics Services. 
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hypothetical function with the gene ID TGME49_220480, which lacks sequence 
homology to any proteins of known function. The remaining proteins are either 
predicted to be trafficked to other locations within the cell, such as the 
mitochondrion or nucleus, or do not contain a signal peptide. If these predicted 
localizations are accurate, it is unlikely that GRA41 would ever encounter these 
proteins within the parasite.  
Using a combination of co-immunoprecipitation and yeast two-hybrid 
analysis, I have generated a list of potential GRA41 interactors. Future studies 
should focus on verifying potential interaction partners and using genetic 
approaches to determine their impact on the phenotypes associated with the loss 
of GRA41. 
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Chapter 5 : Characterization of GRA41 During Parasite Differentiation 
T. gondii parasites circulating in North American and Europe are composed 
of many different strains belonging to three distinct clonal lineages. Historically, the 
majority of human infections have been caused by Type II strains, with a minority 
of infections caused by either the Type I or Type III strains. Type III strains are 
common causes of animal infection, while overall rates of infection with the highly 
virulent Type I strain are low in both humans and animals (Howe and Sibley 1995). 
Of the three strains, the highly virulent Type I strain, RH, and the moderately 
virulent Type II strain, Prugniaud (Pru) are commonly used to study parasites in 
tissue culture and mouse models of infection. The RH strain is highly virulent in 
mice, with a single parasite capable of causing mortality during the acute phase of 
the disease (Johnson, McDonald et al. 1979), making it a useful model to 
investigate the tachyzoite lytic cycle and identify key virulence factors. The Pru 
strain is capable of spontaneously switching from the rapidly replicating tachyzoite 
form to the slow-growing, tissue cyst-forming bradyzoite stage under normal 
culture conditions (Soete, Fortier et al. 1993) or using high pH stress conditions 
(Soete, Camus et al. 1994). The high switching efficiency of the Pru strain, 
combined with relatively modest virulence in the mouse model (few mice succumb 
to the acute stage of infection if doses are kept below 105/mouse,Figure 5.3) 
makes it ideal for studying the tachyzoite to bradyzoite switch and the chronic 
stage of the infection in vivo.  
The initial characterization of TgGRA41 was performed in a derivative of the 
RH strain of T. gondii, allowing for a complete characterization of this protein’s role 
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during the tachyzoite lytic cycle. However, to determine the role of TgGRA41 in the 
bradyzoite stage of infection, I utilized to the Pru strain to facilitate our analysis of 
this stage. To do this, I endogenously tagged TgGRA41 in the Pru strain as 
described for the RH strain to determine if TgGRA41 is expressed during the 
bradyzoite stage of development and to analyze its localization at this time. I then 
generated a knockout of the TgGRA41 in the Pru strain in order to determine the 
impact of its loss during bradyzoite development and in vivo infection. 
TgGRA41 is expressed in a Type II strain and localizes to the wall of bradyzoite 
tissue cysts 
In order to confirm that GRA41 is expressed in tachyzoites and bradyzoites 
of a Type II strain, sequences encoding a carboxy-terminal (C-terminal) triple-
hemagglutinin (HA) tag were introduced into the endogenous locus in the 
Pru∆Ku80∆hxgprt strain just before the stop codon, using a previously described 
approach (Fox, Falla et al. 2011). Western blot analysis of protein extract from the 
endogenously tagged strain revealed a single band migrating at approximately 20-
25 kDa, which is approximately the same size as the predicted molecular weight 
of the tagged protein, 24 KDa (Figure 5.1A, below).  
Since the doublet pattern found in Type I parasites (Figure 3.3A, above)was 
not visible in the Type II strain, I conducted a sequence alignment using Clustal 
Omega of the predicted protein sequences for Type I and Type II strains 
(ToxoDB.org) to determine if any polymorphisms could account for the differences 
in the banding patterns between the two strains (Figure 5.1B, below). Overall, there 
is high identity between the two sequences (97%), with only 6 amino acids differing 
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between the two protein sequences. These include a cysteine at position 12 of the 
Type I sequence that is a tryptophan in the Type II strain, two glutamic acids at 
positions 124-125 that are glycines in the Type II strain, a serine at position 134  
 
Figure 5.1 GRA41 is expressed in a type II strain and localizes to 
the wall of bradyzoite tissue cysts 
(A) GRA41 was tagged at the endogenous locus with a triple 
hemagluttinin tag in the Type II strain, Pru∆Ku80. Western Blot 
analysis of the tagged line compared to the untagged parental with 
an antibody directed against the hemagluttinin tag shows a single 
protein of slightly over 20 kildoDaltons in the tagged line only. (B) 
Clustal Omega alignment of the predicted protein sequences of the 
Type I and Type II strains with differences between the sequences 
boxed in red. (C) Immunofluorescence analysis of the GRA41 
hemagluttinin tagged line after conversion to bradyzoites (7 days 
of pH stress). HA = hemagluttinin, Dolichos = Dolichos biflorus 
agllutinin, Overlay = merge of HA, Dolichos and DAPI (DNA) 
channels.  
that is a threonine in the Type I strain, a lysine a position 174 that is a glutamic 
acid in the Type II strain and a glutamic acid in the final position 179 that is a lysine 
in the Type II strain. Many of these are potential candidates for post-translational 
modifications that could impact the electrophoretic mobility of the protein by SDS-
PAGE analysis. 
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The localization of GRA41 in a bradyzoite tissue cyst was then examined 
by immunofluorescence microscopy conducted after tachyzoites were converted 
to bradyzoite cysts by 7 days of pH stress with CO2 deprivation. GRA41 protein 
was visualized by probing with an antibody directed against the hemagluttinin tag 
of the endogenously tagged strain. The cyst wall of the bradyzoite was visualized 
by staining with Fluorescein-conjugated DBA; individual bradyzoites are also 
shown in the green channel due to the presence of a GFP-encoding gene under 
the control of the bradyzoite-specific LDH2 promoter that is stably integrated into 
the Pru∆ku80∆hxgprt strain (Cleary, Singh et al. 2002). Organelles containing DNA 
(i.e. nucleus, apicoplast) are stained with DAPI. As expected for a dense granule 
protein that is localized to the vacuole in tachyzoites, GRA41 is enriched in the 
cyst wall of the newly formed bradyzoite tissue cyst (Figure 5.1C, above). 
Knockout of GRA41 in a Type II Strain recapitulates resistance to ionophore 
induced death 
To further study the role of GRA41 in the bradyzoite stage of the parasite, I 
generated a knockout of the gene by replacing the entire coding sequence with the 
selectable marker hypoxanthine-guanine phosphoribosyltransferase (HXGPRT) 
through double homologous recombination into the Pru∆ku80∆hxgprt parental 
strain, hereafter referred to as Pru∆ku80 (Fox, Falla et al. 2011) (Figure 5.2A, 
below). Parasites transfected with the knockout vector (pGRA41KO) and stably 
expressing HXGPRT were selected by resistance to mycophenolic acid and 
xanthine and cloned by limiting dilution. Clones were imaged live on a Leica 
inverted DMI6000B microscope to determine whether or not they were expressing 
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GFP. Since a GFP expression cassette is present within the pGRA41KO vector 
but is downstream of the 3’ flanking region, any GFP positive parasites are likely 
to be the result of integration of the construct by single homologus recombination 
rather than double homologous recombination. A single clone was isolated that 
was GFP negative out of over 150 clones screened, which was then shown to have 
correct integration of the construct by PCR (Figure 5.2B, below). Based on the 
nature of the genetic disruption expected from double recombination of the 
knockout construct (pGRA41KO, (Figure 5.2A, below)) the established clone 
represents a functional knockout and is unlikely to produce any GRA41 protein. I 
then assessed whether the complete knockout of GRA41 in the Pru∆ku80 strain 
recapitulated the iiDeath- phenotype seen in GRA41 truncation mutant MBD 2.1 
and the GRA41 Type I knockout. 
Pru∆ku80∆gra41 showed statistically significant increases in survival as 
compared to the parental strain after 10 or 30 minutes of treatment with A23187 
(87% ± 5.5% versus 74% ± 5.2% for the parental strain at ten minutes and 48% ± 
14% versus 28% ± 13% for the parental strain at thirty minutes, p<0.05, Figure 
5.2C, below). Despite the differences in timing of the iiDeath phenotype as 
compared to the RH strain, which has been shown previously (Lavine, Knoll et al. 
2007), the Pru∆ku80∆gra41 recapitulates the decrease in sensitivity to ionophore 
induced death found in the type I knockout, suggesting that Gra41 likely plays a 
similar role in Type II strains as it does in Type I. 
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Preliminary Data on Impact of GRA41 Loss on Tissue Cyst Development 
Having established that GRA41 plays a similar role in resistance to 
ionophore induced death in a type II strain as it did in a type I strain, I then utilized 
Figure 5.2 Complete knockout of GRA41 in a Type II Strain 
recapitulates the iiDeath- phenotype seen in Type I Knockout.  
(A) Diagram shows strategy used to knockout GRA41 by double 
homologous recombination replacing the GRA41 locus with the 
HXGPRT selectable marker. Colored arrow heads indicate 
beginning and end of genomic regions used to drive homologous 
recombination of pGRA41KO vector with target locus in 
chromosome X (ChrX). Arrows indicate relative direction of 
transcription of the three genes depicted and black arrow heads 
represent primers p1, 2 and 3 used to corroborate integration. (B) 
PCR analysis of DNA from parental strain (par) and knockout (ko) 
using either a primer pair expected to produce an amplicon in both 
parental and knock strains (p1-p2, left panel) or a test primer pair that 
would produce a product only if the GRA41 gene were replaced (p2-
p3, right panel). (C) Extracellular parasites of the parental and 
knockout lines were exposed to 1 µM A23187 for 10 or 30 minutes 
and survival rate was determined as in Fig. 1. Bars are average of 
three independent experiments and error bars represent standard 
deviation. Asterisk denotes statistical significance based on the 
results of an unpaired Student’s t-test with a p-value of <0.05. 
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the type II GRA41 knockout to determine the role GRA41 plays in the tissue cyst 
stage of the T. gondii life cycle. To do this, host cells were infected with parasites 
for 2-4 hours before using an established pH stress protocol to induced conversion 
to the bradyzoite stage (Weiss, Laplace et al. 1995). The pH stress media was 
replaced every two days and the cells were kept in a CO2 deprivation incubator to 
ensure high rates of stage switching were achieved. Conversion to bradyzoites 
was measured utilizing rhodamine-conjugated DBA, which binds to glycosylated 
proteins in the bradyzoite cyst wall (Scholytyseck, Mehlhorn et al. 1974, Tomita, 
Bzik et al. 2013). Cells were fixed at four or seven days post infection to look for 
defects in tissue cyst formation or maintenance. A minimum of 100 vacuoles were 
scored as either DBA positive or negative. Small clusters of DBA negative 
vacuoles containing 1-2 parasites that appeared to have remained as tachyzoites, 
egressed and reinvaded nearby host cells were counted as a single DBA negative 
vacuole, since these parasites likely came from one original vacuole. Though there 
was no statistically significant difference in the percentage of DBA positive 
vacuoles between the parental and knockout strains at four days post infection 
(73%±16% and 53%±29% respectively, Figure 5.3A, below), there is a significant 
difference between the two strains at seven days post infection (75%±7% and 
20%±12%, respectively, **, p<0.01), suggesting that the knockout parasites form 
bradyzoite cysts initially, but fail to maintain these bradyzoite cysts. Some of the 
cysts formed by the knockout parasites had lost cyst wall staining at seven days 
post infection, while many others had egressed and reinvaded, either as 
tachyzoites or bradyzoites.  
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To further investigate bradyzoite formation under in vivo conditions, female 
CBA/J mice were injected by Dr. Arrizabalaga with 103, 104 or 105 parasites per 
mouse. Mice were allowed to progress from an acute infection to a chronic 
infection for 28 days before brains and blood were harvested by myself and Tamila 
Garbuz. The average number of tissue cysts per brain was measured by fixing and 
staining brain homogenate with rhodamine-conjugated DBA for visualization by 
fluorescent microscopy. Successful infection of mice containing no cysts was 
verified by testing mouse serum against T. gondii antigens by dot blot analysis. At 
a low dose (103 parasites/mouse), very few cysts were found in each mouse brain 
for both the parental and the knockout strain and no differences were seen 
between the two strains (Figure 5.3B, below). However, at a slightly higher dose 
(104/mouse), the number of cysts is almost two-fold higher in the knockout as 
compared to the parental (91 cysts versus 39, p<0.1, Figure 5.3B, below). Due to 
a relatively small sample size, this difference is not statistically significant for a 
cutoff of p<0.05, but is trending toward statistical significance. At the highest dose 
(105/mouse), the knockout strain showed highly variable results, with two of the 
mice not showing any evidence of cysts and two showing high numbers of cysts 
as compared to the parental strain (Figure 5.3B, below). It is not clear whether or 
not the lack of cysts in some of the mice at this dose is due to variability in the 
counting method (since only a small percentage of the total brain material is 
imaged), the failure of parasites to reach the brain or that cysts were too small and 
could not be imaged with the magnification used for counting. When combined with 
the in vitro switching  
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Figure 5.3 Differentiation of Type II Gra41 Knockout 
(A) Parental or GRA41 knockout parasites were allowed to form 
bradyzoite cysts under pH stress for 4 or 7 days before parasites 
were fixed and cyst walls were stained using rhodamine-
conjugated DBA. Bars are average of three independent 
experiments and error bars represent standard deviation. Double 
asterisk denotes statistical significance based on the results of an 
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unpaired Student’s t-test with a p-value of <0.01. (B) Female 
CBA/J mice were infected with parental (WT) or GRA41 knockout 
(KO) parasites at the indicated doses and allowed to progress to 
chronic infection for 28 days before brains were harvested and 
cysts counted following staining with rhodamine-conjugated DBA. 
Individual mice are presented as data points in each treatment and 
error bars represent standard deviation. ‡ denotes statistical 
significance based on the results of an unpaired Student’s t-test 
with a p-value of <0.1. 
data, the in vivo cyst formation data suggests that the bradyzoite cysts from 
the knockout strain may have a defect in maintenance, leading to their 
reconversion to tachyzoites, which then invade additional host cells and lead to the 
formation of more cysts. However, without conducting an analysis at multiple time 
points during bradyzoite infection with additional animals, the exact interpretation 
remains unclear. 
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Chapter 6 : Discussion 
Calcium-dependent signaling is central to the propagation of parasites of 
the phylum Apicomplexa, including the causative agent of malaria, Plasmodium 
falciparum, and the opportunistic pathogen T. gondii. Calcium-dependent events 
underlie the motility, invasion, and egress of these parasites and thus calcium 
homeostasis and fluxes are tightly controlled. Calcium signaling is proposed to be 
an attractive drug target for controlling these parasitic infections, due to its 
essential nature and uniqueness from vertebrate calcium-dependent signaling 
pathway. While many of the effectors of calcium that drive events of the lytic cycle 
in both Plasmodium species and T. gondii have been identified, much remains 
unknown about how these calcium fluxes are regulated. In an effort to address this 
knowledge gap our lab has used a forward genetics approach to identify genes 
that influence T. gondii’s sensitivity to calcium fluxes, specifically those induced by 
the calcium ionophore A23187. Surprisingly, I have discovered that a secreted 
protein, which resides within the parasitophorous vacuole during parasite 
intracellular growth, influences several calcium related events in both intra and 
extracellular parasites. These results suggest a role for PV proteins in the 
regulation of calcium homeostasis, timing of egress, and parasite division. 
Additionally, preliminary results investigating the impact of this protein on 
bradyzoite tissue cyst formation suggest this protein is also required for normal 
cyst maintenance. 
The novel dense granule protein GRA41 was first identified through the 
sequencing of a mutant resistant to extracellular exposure to the ionophore 
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A23187. Normally, exposure to this calcium ionophore for over thirty minutes 
renders extracellular parasites non-invasive, which, for this obligate intracellular 
parasite, results in death. While this phenomenon, known as ionophore induced 
death (iiDeath), has been known and exploited for decades (Mondragon and 
Frixione 1996, Black, Arrizabalaga et al. 2000), the underlying mechanism is not 
well understood. It has been proposed that prolonged exposure to elevated 
calcium, which normally induces secretion of adhesive molecules required for 
invasion, exhausts the contents of the secretory organelles that harbor such 
proteins. Other plausible mechanisms include toxic effects from elevated 
cytoplasmic calcium levels, and changes to the calcium sensitivity of the molecules 
and machinery that regulate secretion. I have actually detected that following a 
one-hour ionophore exposure, the levels of micronemal proteins do not change 
compared to untreated parasites but the ability to elicit micronemal secretion upon 
subsequent ionophore exposure is significantly affected (Figure 4.1, above). This 
observation would indicate that iiDeath is not merely the consequence of the 
exhaustion of proteins to be secreted, but of an alteration in the sensitivity to 
calcium, which would lead to a reduction in active secretion. In this context, I 
hypothesize that the resistance to iiDeath of the parasites lacking GRA41 is due 
to an altered sensitivity to the ionophore, brought upon by the clear changes in 
calcium regulation detected in the GRA41 knock out strain. Indeed, the gra41 
mutant strain (MBD2.1) is over-sensitive to the effects of calcium chelation by 
BAPTA-AM (Mondragon and Frixione 1996, Black, Arrizabalaga et al. 2000). It is 
not yet clear whether the altered calcium regulation exhibited by the GRA41 
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knockout strain is due to a direct effect of lack of GRA41 or an indirect 
consequence of how the parasites adapts to the loss of GRA41. The latter 
explanation is supported by the observation that the mutant strain has an elevated 
level of cytosolic calcium that is not corrected by genetic complementation. 
Nonetheless, lack of GRA41 does seem to affect calcium regulation as the mutant 
parasites exhibited dysregulated calcium uptake, a phenotype that is reverted by 
complementation. While I have yet to elucidate the exact mechanism by which the 
knockout parasites are adapting, I have observed that the premature egress 
phenotype is very stable during culture, suggesting that the mutant and knockout 
strains could adapt to this change in egress timing by modifying one of the other 
steps in the lytic cycle (i.e. increasing attachment) which is also dependent on 
calcium signaling processes. Though it is difficult to determine the specific function 
of GRA41, the calcium uptake defect of extracellular parasites suggests that 
GRA41 is involved in regulating calcium homeostasis. Higher levels of cytosolic 
calcium and increased rates of calcium uptake by extracellular parasites shows 
how the parasites responds to the loss of GRA41. 
How a protein that resides outside of the parasite but within the 
parasitophorous vacuole might affect calcium regulation within the cytoplasm of 
the parasite is puzzling, especially considering that some of the phenotypes related 
to its deletion, such as iiDeath resistance, manifest only once the parasites are 
extracellular. It is plausible that the protein, which is in the dense granules before 
secreted, has a role within this organelle that influences calcium homeostasis in 
extracellular parasites. Nonetheless, there is no evidence that dense granules 
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accumulate significant amounts of calcium (Bonhomme, Pingret et al. 1993) or are 
involved in the regulation of calcium homeostasis or fluxes. It is also conceivable 
that GRA41, while in the PV, directly or indirectly influences the physiology of the 
vacuole, which in turns affects that of the parasite. In such a model, the absence 
of GRA41 would alter the physiology of the intracellular parasite and, once outside, 
these parasites would react differently to external stimuli such as the calcium 
ionophore.  
Though the PV lumen has long been considered physiologically at 
equilibrium with the host cell through a nonselective pore (Schwab, Beckers et al. 
1994), whose components were recently identified (Gold, Kaplan et al. 2015), 
several studies indicate that ionic concentration of the PV can vary in respect to 
that of the host cytoplasm during intracellular growth. For instance, measurements 
of calcium levels using non-ratiometric indicators in the PV have shown that 
calcium is concentrated in the PV relative to the host cell cytoplasm and the 
frequency of this calcium sequestration increases as egress approaches (Pingret, 
Millot et al. 1996). Interestingly, one of the most abundant PV proteins, GRA1, has 
been shown to bind calcium (Cesbron-Delauw, Guy et al. 1989), which suggests 
a potential mechanism for this calcium sequestration. The calcium concentration 
of the Plasmodium PV has been determined through the use of ratiometric 
indicators to be approximately 40 μM, many fold higher than the 20 nM that would 
be expected if the PV calcium levels were in equilibrium with the host red blood 
cell’s cytosol (Murphy, Berkowitz et al. 1987, Gazarini, Thomas et al. 2003). 
Additionally, the same study showed that depletion of calcium in the Plasmodium 
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PV leads to a depletion of intracellular calcium stores, which suggests that the 
parasite depends on the sequestration of calcium in the PV to maintain its 
intracellular pools of calcium (Gazarini, Thomas et al. 2003). It is possible that 
similar mechanisms are regulating calcium levels within the T. gondii PV. 
Interestingly, calcium is not the only ion which the parasite regulates the 
concentration of within the PV; it has recently been shown that the pH of the 
vacuole decreases as egress approaches and this increased acidification is 
associated with enhanced parasite motility and protein secretion (Roiko, Svezhova 
et al. 2014). While it is possible that one or more dense granule proteins that T. 
gondii secretes into its vacuole are responsible for the sequestration of ions as 
egress approaches, it is unlikely that this is occurring in Plasmodium species, since 
the dense granule proteins described to date are restricted to the tissue-cyst 
forming coccidia and are not found in other apicomplexans such as Plasmodium 
(Mercier and Cesbron-Delauw 2015). Therefore, it is possible that these two 
related organisms have evolved different strategies to utilize calcium signaling 
within the context of the calcium-poor cytosol of their host cells. 
It is unlikely that GRA41 binds calcium directly, since bioinformatic analysis 
fails to identify any conserved calcium binding domains (SMART, NCBI, Prosite, 
Interpro) and recombinant GRA41 protein fails to bind calcium in vitro (Figure 4.6, 
above). Rather, I hypothesize that GRA41 might influence physiological calcium 
homeostasis by its localization and functional role within the tubulovesicular 
network (TVN). Loss of GRA41 leads to altered morphology of the TVN, which 
interestingly has been proposed to play a role in calcium storage based on electron 
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microscopy studies (Bonhomme, Pingret et al. 1993). Nonetheless, other dense 
granule proteins that localize to the membranes of the TVN are also critical for its 
formation (Mercier, Dubremetz et al. 2002), but do not seem to appear to affect the 
same of processes influenced by GRA41. The loss of the TVN in parasites lacking 
GRA2 leads to a variety of phenotypes, including the formation of vacuoles 
containing poorly organized parasites that egress erratically (Muniz-Hernandez, 
Carmen et al. 2011), altered presentation of antigens to the host immune system 
(Lopez, Bittame et al. 2015), decreased ingestion of host cytosolic proteins (Dou, 
McGovern et al. 2014) and decreased virulence in mice (Mercier, Howe et al. 
1998). However, I have shown that the loss of GRA2 does not phenocopy the 
iiDeath resistance of the GRA41 knockout and forward genetic mutant, suggesting 
that the disruption of the TVN might not be the underlying reason for the iiDeath 
resistance of GRA41(Figure 4.5, above). Rather, it appears that the iiDeath 
resistance of the GRA41 knockout strain is a direct effect of GRA41 by a novel 
mechanism that has yet to be completely discerned. Nonetheless, there remains 
the possibility that although the TVN is structurally affected in both the GRA41 and 
GRA2 knockout strains, the nature, level and the functional consequences of that 
effect might be different between the two mutant strains. For example, the loss of 
GRA41 might prevent the formation of specific protein complexes within the PV 
which are required for normal egress timing, which might explain why the loss of 
GRA2 leads to erratic egress that occurs with normal timing. 
At the current time, it is unclear which of the pleiotropic effects of GRA41 
loss is the primary impact of its loss and which are simply downstream defects. 
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However, one of the most severe and distinct phenotypes of the GRA41 knockout 
strain is a premature egress from the host cell. Natural egress from host cell can 
be an active process dependent on calcium fluxes (Moudy, Manning et al. 2001). 
Two alternative hypotheses to explain the premature egress are 1) that the altered 
TVN, which might normally act as a mechanical barrier, allows for early exit and 2) 
that the dysregulation of calcium homeostasis results in changes in the timing of 
egress. The fact that other mutant parasites lacking a normal TVN, such as the 
GRA2 knockout, don’t have a premature egress phenotype would argue against a 
model in which the altered TVN, caused by gra41 disruption, allows for early 
egress. To further separate these two phenotypes, complementation studies with 
modified (i.e. truncated, mutated) forms of GRA41 in the knockout background 
should be performed to determine if these two phenotypes can be functionally 
linked to domains or residues within GRA41. Additionally, the only other dense 
granule protein whose loss leads to an early egress phenotype similar to the 
GRA41 knockout is GRA22. However, the GRA22 knockout does not exhibit any 
obvious defect in TVN formation (Okada, Marmansari et al. 2013), suggesting that 
GRA41 plays a structural role within the TVN that is independent from its role in 
egress and, by inference, calcium-dependent signaling processes within the 
parasite. It remains unclear whether or not these two proteins are interacting 
together directly or within the same pathway to influence the timing of egress. 
Though preliminary interaction studies failed to identify GRA22 as a potential 
interactor as GRA41, future studies to expand and refine this list of GRA41 
interactors and to create a strain lacking both GRA22 and GRA41 would address 
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some of these questions. Considering that tight control of calcium levels is needed 
for egress, it is plausible that the early egress phenotype of the GRA41 knockout 
is related to the dysregulation of calcium seen in this strain. Interestingly, the 
MBD2.1 mutant, as well as the GRA41 knockout, show a slight but consistent 
increase in the rate of calcium dependent iiEgress ((Black, Arrizabalaga et al. 
2000) and unpublished data, LaFavers and Arrizabalaga). Additional support for a 
connection between early egress and calcium dysregulation in the mutants, is the 
fact that the GRA41 knockout is much more sensitive to DTT-induced egress than 
the parental strain. The redox reagent DTT is proposed to induce egress by 
activating NTPases located in the PV since it is capable of activating isolated 
enzyme (Bermudes, Peck et al. 1994). Treatment with DTT has also been shown 
to lead to calcium fluxes within the parasite, resulting in induced egress, which can 
be blocked by chelating calcium, indicating that DTT-induced egress is also 
calcium dependent (Stommel, Ely et al. 1997, Borges-Pereira, Budu et al. 2015). 
Unlike calcium ionophores such as A23187, DTT is not capable of inducing egress 
at early stages of parasite vacuole formation and requires longer growth times (~36 
hours) for vacuoles to consistently egress. This suggests that DTT-induced egress 
might be dependent on processes preceding natural egress and is therefore a 
more accurate model for what is happening in natural uninduced egress (Stommel, 
Cho et al. 2001). In this context, the ability of the GRA41 knockout strain to undergo 
DTT-induced egress at 24 hours is consistent with its early egress phenotype. The 
formation of more than two daughter parasites in the dividing GRA41 knockout 
strain could also occur as a result of calcium dysregulation rather than simply being 
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an additional function of GRA41. Knockdown of the calcium-dependent kinase 
CDPK7 has previously been shown to disrupt normal division (Morlon-Guyot, Berry 
et al. 2014). Additionally, experiments to identify novel proteins in the inner 
membrane complex (IMC) of the parasite, which serves as the scaffold for 
daughter cell formation (Harding and Meissner 2014), identified a protein (ISC6, 
TgGT1_267620, ToxoDB.org), that localizes to the IMC and contains a C2 calcium 
binding domain (Chen, Moon et al. 2017), which could suggest a link between 
calcium and daughter parasite formation in T. gondii. 
Of note is the fact that GRA41 is not annotated as a protein encoding gene 
in the latest version of the T. gondii genome database. This locus was denoted as 
a gene in earlier annotations with both transcriptomic and proteomic corroborating 
evidence. As I have shown there is clearly a protein encoding locus in that genomic 
region; underscoring the limitation of genome annotations. One of the drawbacks 
of GRA41 not being denoted as a protein in the current annotated genome is that 
it is not considered when analyzing datasets that rely on the annotation. In the 
many gene expression studies, mappings of post-translational modifications, and 
sequencing of mutant strains that have been undertaken in the last few years, 
GRA41 has not been included, significantly reducing our ability to understand its 
function. For example, the presence of certain post-translational modifications 
could provide clues to how GRA41 is associated with the TVN membrane. Though 
GRA41 lacks an amphipathic alpha helix (Helical Wheel Predictions, RZ Lab) like 
those found in other TVN-localized proteins such as GRA2 (Mercier, Cesbron-
Delauw et al. 1998), it does contain a predicted palmitoylation site at Cys26 (CSS-
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Palm, Cuckoo Workgroup) that could explain membrane association. Though the 
palmitoylome for T. gondii has been published (Foe, Child et al. 2015), GRA41 
was not included in the database at the time and any potential palmitoylation 
modifications were not mapped. As a result, future directions for the study of 
GRA41 would include mapping post-translational modifications and determining 
how they impact protein localization and function by mutational analysis.  
In this context, the difference in electrophoretic mobility between the Type I 
and Type II GRA41 proteins (i.e. migrating as a doublet in Type I and a singlet in 
Type II strains) combined with the results of an alignment between the two proteins 
could help to identify residues that are differentially modified between the two 
strains. Though the modification responsible for the difference in electrophoretic 
mobility is likely to not be essential for overall protein function, it is possible that it 
could lead to subtle differences in protein function between the two strains. Such 
differences could prove informative for both the study of GRA41 and differences 
between Type I and Type II strains. Many of the amino acids which are different 
between the Type I and Type II GRA41 amino acid sequences could be 
responsible for the observed mobility difference. For example, the cysteine found 
at position twelve in the Type I strain could participate in the formation of a disulfide 
bond, which has been shown to lead to the production of a protein doublet by SDS-
PAGE analysis (Ruiz, Chng et al. 2010). This cysteine is also predicted as a 
possible palmitoylation site by CSS-Palm, which would be lost if the amino acid at 
this location were a tryptophan, as it is in the Type II strain (Ren, Wen et al. 2008). 
The glutamic acid residues at positions 124, 125 and 179 may also be modified, 
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such as in the addition of a CO2 molecule to form gamma-carboxyglutamic acid. 
The resulting modified amino acid has two negatively charged groups which have 
been found to be important in coordinating divalent cations, such as calcium, in 
blood clotting factors (Furie, Bouchard et al. 1999). Though serine residues are 
capable of receiving many types of modifications, including phosphorylation and 
glycosylation, threonine is also capable of accepting these types of modifications, 
making the conversion of the serine to threonine at position 134 a somewhat less 
likely candidate for the differences in protein migration observed (Blom, Sicheritz-
Ponten et al. 2004). Finally, lysines such as the one found at position 174 can be 
modified by as many as 12 different post-translational modifications, including 
acetylation, methylation and ubiquitination (Liu, Wang et al. 2014). 
The discovery of GRA41 as a novel dense granule protein with a role in 
calcium-dependent events helps to both answer and create new questions about 
the role of the PV in these signaling processes. This work demonstrates that the 
parasite is dependent on a dense granule protein for normal calcium homeostasis, 
but it is still unclear how and if the parasite might regulate PV calcium levels 
independent of the host cell cytosol in the presence of a nonselective PVM pore 
(Schwab, Beckers et al. 1994). The explanation for this might be the existence of 
additional calcium binding proteins that, in addition to GRA1 (Cesbron-Delauw, 
Guy et al. 1989), could bind and sequester calcium within the PV. Future efforts to 
directly measure calcium concentration in the PV of GRA41 mutant strains might 
shed light on the specific function of this protein. 
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The localization of GRA41 to the TVN suggests that this membranous 
structure may also play a direct or indirect role in the physiological regulation of  
 
Figure 6.1 Proposed model for phenotypes associated with Loss 
of GRA41 in Type I Strain 
Host cell containing a parasitophorous vacuole with four parasites 
(black) and GRA41 present in the vacuole (left) shows wild-type 
phenotypes for TVN structure, calcium levels/uptake, egress 
timing and cell division. When GRA41 is lost (vacuole on right, grey 
parasites) a variety of phenotypes are observed. The model 
proposes possible links between the phenotypes. Links with more 
than one possibility and unconfirmed phenotypes are labeled in 
red. 
the parasite,  pointing to a novel function for this poorly understood element of 
intracellular parasite development. Thus, in conjunction with previous knowledge, 
our results underscore the critical importance of the parasitophorous vacuole and 
its contents in the life cycle of T. gondii and, likely, of related parasites. To begin 
to address the question of how GRA41 performs its functions, I used two different 
approaches to create a list of potential interactors of GRA41. The co-
immunoprecipitation approach has the benefit of assessing interactions as they 
occur naturally, but it has many drawbacks. Co-immunoprecipitation protocols 
must be optimized for each protein individually, which can be time and labor 
intensive and still may not yield reproducible results. This is because it is difficult 
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to capture transient or weak interactions, especially when strong detergents and 
sonication are necessary to fully solubilize a target protein such as GRA41, which 
has been shown to partition as a membrane protein (Figure 3.4, above). A single 
successful co-immunoprecipitation was conducted on GRA41 using the strain 
which has GRA41 endogenously tagged with HA and harvesting intracellular 
parasites, which identified several potential interactors. Of these, some were 
previously characterized dense granule and rhoptry proteins, while others are 
proteins of hypothetical function that contain a signal peptide (characteristics 
common to dense granule proteins). Two of these proteins that are most likely to 
be bona fide interactors are GRA3 and GRA9, both of which at least partially 
localized to the tubulovesicular network where GRA41 resides (Adjogble, Mercier 
et al. 2004, Kim, Ahn et al. 2008). The large number of rhoptry proteins, which all 
traffic to the membrane of the parasitophorous vacuole (Soldati, Lassen et al. 
1998, El Hajj, Lebrun et al. 2007, Peixoto, Chen et al. 2010), are also potentially 
bona fide interactors, since the tubulovesicular network can come into close 
contact with the PVM. If these interactors are real, they could suggest a possible 
function of GRA41 wherein it helps form the links between the TVN and the PVM. 
If these links are required for the correct morphology of the TVN, they could explain 
why loss of GRA41 leads to disruption of the TVN. It is important to note that none 
of these interactions have been validated by targeted co-immunoprecipitations, 
which would be necessary to demonstrate that they are true interactors. 
Using the yeast two hybrid approach allows us to continue our search for 
interactors while avoiding some of the pitfalls of the co-immunoprecipitation 
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approach. When samples do not need to be lysed and solubilized, there is no 
concern that weak interactions are being missed. Since the yeast two-hybrid 
approach takes place in a heterologous system, it will only give direct interactors, 
rather than proteins that are part of the same complex as the target protein but do 
not bind it directly. Additionally, because the prey fragments used in the library are 
often smaller than the entire protein, it is possible to determine what region of the 
prey protein that the bait protein is binding. Using this technique has generated a 
list of 11 high confidence potential interactors for GRA41. Of these, probably the 
most intriguing is GRA1, which is a dense granule protein that localizes to both the 
lumen of the PV as well as the TVN. In addition to partially sharing localization with 
GRA41, GRA1 also contains a motif that has been shown to bind calcium 
(Cesbron-Delauw, Guy et al. 1989). It is possible that GRA1 acts to sequester 
calcium within the vacuole and a potential interaction with GRA41 would allow it to 
associate with the TVN. Of the remainder of the list, only a single protein of 
hypothetical function is predicted to be secreted by Psort (Horton, Park et al. 2007), 
though many of the remaining proteins do have signal peptides. Unfortunately, 
none of the high confidence proteins on the yeast two-hybrid list overlap with the 
high confidence proteins from the co-immunoprecipitation, likely due to the 
differences and drawbacks of each approach. Since interactions of lower 
confidence for both data sets were excluded from the analysis, it is possible that 
are some genuine interactors that show up on both lists but are not listed as high 
confidence due to low abundance of the potential interactor. The yeast two-hybrid 
approach is likely to capture interactions that are possible based on protein 
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structure, but may not occur within the parasite because the proteins are localized 
to different areas within the cell. They are also incapable of detecting indirect 
interactions with multiple components of a protein complex. The co-
immunoprecipitation approach is limited by the optimization of the solubilization 
and pull-down of the target antigen, but is more likely to be able to pull down large, 
multi-protein complexes. To validate these potential interactors, it will be necessary 
to show co-localization, which may require immunoelectron microscopy to 
potential interactions between the PVM-localized rhoptries and the TVN-localized 
GRA41. A proximity-labeling approach, such as BioID (Roux, Kim et al. 2013) or 
APEX2 (Lam, Martell et al. 2015), could also help to verify transient or weak 
interactions that show up in the yeast two-hybrid screen but are not seen using a 
traditional co-immunoprecipitation approach.  
A complete knockout of GRA41 in a Type II strain recapitulates the 
resistance to iiDeath seen in both the Type I knockout and forward genetic mutant, 
suggesting that the overall role in calcium processes is conserved between the two 
strains. However, no significant defect in plaque formation was detected for the 
knockout strain and additional phenotypes found in the Type I knockout strain were 
not tested, so it remains unclear the exact function GRA41 might play in a Type II 
strain. Determining whether or not the Type II knockout recapitulates all of the 
phenotypes of the Type I knockout is particularly interesting in light of the 
differences in electrophoretic mobility for the tagged proteins described above, 
making it likely that GRA41 is differentially modified in the two different strains.  
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The most important question that generating a Type II knockout allows us 
to answer is whether or not the loss of GRA41 plays any role in tissue cyst 
formation or maintenance and what role it plays during in vivo infection. Here I 
show preliminary data that the knockout of GRA41 shows a significant decrease 
in the percentage of vacuoles with an intact cyst wall at 7 days when compared to 
the parental strain. Since this phenotype is not seen at four days, it suggests that 
the loss of GRA41 does not impair the parasite’s ability to form a cyst wall, but that 
the cyst wall is not able to be maintained, even in the presence of continued pH 
stress. It is unclear whether or not this failure to maintain the cyst wall is due to 
defects in calcium signaling as seen in the Type I strain or structural defects in the 
cyst wall. A pilot in vivo experiment shows that the loss of GRA41 shows highly 
variable phenotypes according to the dose used to infect mice. At a low dose, cysts 
counts are very low in both the parental and knockout-infected mice and no 
difference is seen between the two groups. However, at a higher dose, there is a 
2-fold increase in the number of cysts/mouse brain. This increase is also seen in 
the cyst-containing brains of the mice that received the highest dose of knockout 
parasites, though many of the brains in this group have no detectable cysts, so the 
average number of cysts is equivalent in the parental and knockout strains. Follow-
up mouse experiments would need to address the issue of acute virulence by 
increasing the highest dose to one that is lethal in at least some of the mice. This 
would allow us to determine the impact that GRA41 has on virulence during the 
acute infection. Given the high variability in the tissue cyst count data from the pilot 
experiment, follow-up experiments should increase the number of animals 
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assessed to get a more accurate representation of total cyst numbers. Since the 
preliminary results suggest that the knockout strain could have a defect in cyst 
maintenance, which would lead to overall higher cyst counts due to the reactivation 
of cysts to tachyzoites, followed by reinvasion and conversion back to bradyzoite 
cysts, additional experiments examining cyst counts for mice infected with the 
parental and knockout strains at later time points in the chronic infection might help 
support this hypothesis. It is possible that some of the cysts of the knockout strain 
are not able to be visualized with the current protocols due to small size, and it is 
expected that looking at later time points might allow cysts to increase in size 
and/or number. Overall, these results suggest that GRA41 plays an important role 
in the bradyzoite stage of the life cycle and that differences between the Type I 
and Type II proteins could provide important information about the role of specific 
residues and potential posttranslational modifications in phenotypes already 
characterized in Type I tachyzoites. Additionally, since very little is known about 
the calcium regulation of bradyzoite formation, maintenance and reactivation, this 
knockout could play a key role in elucidating the role of calcium in these processes. 
 119 
Chapter 7 : Conclusion and Future Directions  
Conclusion 
Calcium-dependent signaling processes are critical for multiple steps of the 
parasite’s lytic cycle and represent an appealing target for drug discovery 
(Arrizabalaga and Boothroyd 2004). Former members of the Arrizabalaga 
laboratory have used a forward genetic approach to identify and characterize some 
of the key players in these signaling events (Black, Arrizabalaga et al. 2000, 
Garrison, Treeck et al. 2012). Here I describe the characterization of a previously 
generated mutant, MBD2.1, that is capable of surviving prolonged extracellular 
treatment with a calcium ionophore, which renders wild-type parasites unable to 
attach to host cells. I show that the mutation responsible for this phenotype is the 
introduction of a premature stop codon at serine 92 of the protein of hypothetical 
function, TgGT1_069070. Endogenous tagging at this locus reveals that the 
encoded protein is secreted from the parasite organelle known as the dense 
granules into the parasitophorous vacuole in which the parasite resides and 
divides. Once in the vacuole, it traffics to the TVN. Its secretion from the dense 
granule leads to its designation as a GRA protein and given the current published 
GRA proteins in the field, it is specifically designated as GRA41. 
A complete knockout of the locus encoding GRA41 leads to a recapitulation 
of the resistance of extracellular ionophore treatment, while also showing a defect 
in the efficiency of plaquing. This defect is rescued by complementing the knockout 
strain with a wild-type copy of GRA41 and is demonstrated to be largely due to 
premature egress of parasites from host cells. The GRA41 knockout strain also 
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exhibits increased uptake of calcium when extracellular, which was restored to 
normal levels in the complemented strain. A morphological analysis of the 
knockout strain revealed an improperly formed TVN and evidence of atypical cell 
division. A knockout parasite strain with similar TVN disruption (Travier, 
Mondragon et al. 2008) does not exhibit resistance to iiDeath treatment. Current 
efforts to identify protein interaction partners have resulted in a list of unverified 
potential interactors obtained by co-immunoprecipation and yeast two-hybrid 
analysis. 
Studies to investigate the function of GRA41 in the bradyzoite life stage 
were conducted in the Type II Pru strain. Endogenous tagging of the Type II 
GRA41 protein revealed that it localizes primarily to the tissue cyst wall and has a 
unique electrophoretic migration pattern as compared to the Type I Gra41 protein. 
The loss of GRA41 in the Type II strain recapitulated the resistance to ionophore 
induced death seen in the original mutant and Type I knockout strain. This strain 
also shows reduced tissue cyst wall staining of vacuoles following seven days of 
bradyzoite differentiation by pH stress, though this difference is not seen after four 
days of differentiation. A pilot study of chronic mouse infection with the Type II 
knockout strain showed highly variable cyst counts at the highest dose and very 
low cyst counts at the lowest dose, while the middle dose showed adequate cyst 
counts in both the parental and the knockout with somewhat less variability than 
was seen at the top dose. At this middle dose, the knockout strain was shown to 
have an approximately two-fold higher cyst burden as compared to the parental 
strain.  
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Overall, the forward genetic approach to identifying novel regulators of 
calcium signaling processes has provided unexpected and intriguing results in the 
identification of a novel dense granule protein that plays a role in calcium 
sensitivity/uptake, the timing of egress and vacuolar morphology. Though the exact 
mechanism by which this protein performs these important functions remains 
unclear, these results provide many tantalizing clues and avenues for possible 
future work in this area. An original goal of this work was to identify novel potential 
drug targets to be able to develop inhibitors against for treatment of clinical 
toxoplasmosis. Since GRA41 lacks homologues even among most other 
apicomplexans, its uniqueness could be advantageous in developing specific 
inhibitors that would not target host processes. However, the loss of GRA41 is not 
lethal and, in fact, exhibits what could be considered a gain of function phenotype 
in its premature egress from host cells and ability to withstand extended calcium 
ionophore treatment. This suggests that a more viable strategy to target GRA41 
for drug treatment could be to increase either its amount or stability. To test 
whether or not this might be a viable strategy, we could generate a line which 
overexpresses GRA41 under the promoter of a more highly expressed gene (i.e. 
tubulin) and determine what impact his has on parasite growth. 
After the initial identification and characterization of GRA41 from the forward 
genetic approach, it is clear that the forward genetic approach has come with some 
important advantages and limitations. This approach has allowed us to identify a 
novel protein involved in calcium-dependent signaling processes that would have 
easily been overlooked with a reverse genetic approach, due to its lack of 
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conserved domains. Additionally, the calcium-related phenotype by which the 
mutant was isolated gave important clues to GRA41’s function. However, this 
approach has a few key limitations. Specifically, the use of iiEgress/iiDeath 
phenotypes for forward genetic selection has oftentimes resulted in the generation 
of mutants in the calcium-dependent protein kinase 3 (TgCDPK3, (Garrison, 
Treeck et al. 2012)), suggesting that this selection needs to be refined in order to 
identify novel proteins involved in these processes. For example, the knockout of 
GRA41 results in enhanced natural and DTT-induced egress, though the timing of 
ionophore-induced egress is very similar to wild-type parasites. To identify more 
proteins that might play a role in the timing of natural egress, the screen could be 
modified by using DTT as the inducer of the egress rather than the calcium 
ionophore. By isolating parasites that have delayed (i.e. do not egress following 
DTT treatment at 35 hours post infection) or early (i.e. do egress following egress 
treatment before 35 hours post infection) DTT-induced egress, it would be possible 
to identify proteins that play a role in the timing of natural (uninduced) egress. 
Future Directions 
Does the loss of GRA41 impact calcium levels within the parasitophorous 
vacuole? 
Though this work has shown that the loss of GRA41 in a Type I strain leads 
to enhanced calcium uptake in extracellular tachyzoites, it is unclear how a 
secreted protein demonstrates many of its calcium-related phenotypes (decreased 
sensitivity to ionophore treatment, enhanced calcium uptake) when the parasite is 
extracellular. I hypothesize that the calcium levels within the parasitophorous 
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vacuole of parasites without GRA41 are higher than those seen in wild-type 
parasites and that this impacts how the parasites within these vacuoles respond 
to calcium. This is consistent with the premature egress seen in the GRA41 
knockout, since calcium is an important trigger of parasite egress. However, I do 
not have any direct evidence that the calcium levels within the PV are different 
between the strains. To address this, I could load host cells containing parasites 
with chemical calcium indicators that have been shown to traffic to the PV once 
inside the host cell and use previously described methods to measure the calcium 
concentration within the vacuoles (Pingret, Millot et al. 1996). This will help to 
address an important question about how a secreted protein can play a role in the 
calcium homeostasis within the parasite.  
How does GRA41 localize to the tubulovesicular network? 
The localization of GRA41 to a membranous network is unexpected, since 
there is no strong prediction for a transmembrane domain within this protein. 
Attempts to identify an amphipathic alpha helix, such as the one responsible for 
localizing GRA2 to the TVN (Mercier, Cesbron-Delauw et al. 1998), have also been 
unsuccessful. This makes it likely that the localization of GRA41 to this 
membranous network is due to either a post-translational modification or its 
interaction with another protein. To address the first possibility, and also provide 
additional insight into other aspects of GRA41’s biology, I propose to conduct a 
proteomic analysis to identify post-translational modifications of GRA41. Though 
many proteomic data sets currently exist in the online T. gondii genome database, 
GRA41 has not been annotated in any strain of the genome since v7.2 in 2012, so 
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any data sets created after this time did not include GRA41. The only known post-
translational modification of GRA41 are multiple phosphorylation marks from a 
phosphoproteome analysis published before this time (Treeck, Sanders et al. 
2011). The identification of post-translational modifications on GRA41 will help to 
suggest potential modifications that could allow association with a membrane (i.e. 
lipidation) or which may regulate its function. These residues could then be 
mutated to see if they have any impact on the protein’s localization or function. 
What parts of the protein are necessary for the different functions of GRA41? 
Since GRA41 does not have any domains of known/predicted function, this 
has made it difficult to ascribe specific functions to domains of the protein. 
However, the identification of domains with specific functions within the protein can 
help to understand the mechanisms by which GRA41 impacts vacuolar 
morphology and calcium-dependent signaling processes. Previous attempts have 
been made to generate a series of truncation mutants, but these resulted in 
proteins with low or no expression within the parasite, making it difficult to 
characterize their localization or potential phenotypes associated with these 
truncations. Instead, I would take a complementation approach using the 
previously generated knockout of GRA41. I currently have designed a 
complementation construct consisting of GRA41 5’ and 3’ targeting regions 
flanking a GRA41 coding sequence tagged with a triple HA tag. This construct 
could be modified by scrambling the amino acid sequences of alpha helices, 
mutating residues predicted/demonstrated to be post-translationally modified or 
deleting short sequences from the protein. These could then be incorporated into 
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the knockout strain to assess their localization and ability to complement the 
various phenotypes associated with the loss of GRA41. 
What are the protein interaction partners of GRA41? Can any of these explain 
the phenotypes associated with its loss? 
Preliminary attempts to define the GRA41 interactome have generated an 
initial list that will be expanded upon and validated. For this, I propose to take two 
complementary approaches. Due to difficulties encountered with the traditional co-
immunoprecipitation approach, I would instead look to a proximity-based labeling 
approach to identify potential interactors. In this context, APEX2 is an ascorbate 
peroxidase that has been used to label compartments for electron microscopy 
imaging and also to label proximal proteins with a biotin-phenol radical. It was 
recently modified to have high catalytic activity, and can now be used even with 
proteins that have low or medium endogenous expression without the requirement 
of overexpression (Lam, Martell et al. 2015). A fusion between GRA41 and APEX 
will be generated at the endogenous locus, similar to the addition of the 
endogenous HA tag. In the presence of biotin phenol and hydrogen peroxide, this 
fusion protein will add biotin groups to proteins within a 20-nm radius of the fusion 
protein. These proteins can then be isolated using streptavidin-conjugated 
agarose or magnetic beads and identified by mass spectrometry. Since the 
labeling occurs in live parasites, this method is less likely to capture false positive 
from interactors not found within the same location as the protein of interest. It is 
also capable of detecting weak or transient interactions and there are no limits on 
the types of lysis and wash buffers used, since it is not necessary to preserve 
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protein interactions. This method will be used to complement the data generated 
from the co-immunoprecipitation and yeast two-hybrid analysis to prioritize 
candidate proteins. 
Candidate interactors identified in the current data and any additional data 
sets generated from the APEX labeling experiments will be validated by verifying 
colocalization with GRA41 when parasites are intracellular and extracellular (using 
antibodies if available or by generating lines with the potential interactor tagged if 
an antibody is not available). If colocalization is observed, reciprocal co-
immunoprecipitations will be performed in a strain tagged with both GRA41 and 
the potential interactor. To account for the possibility that these interactions are 
transient, proteins will first be cross-linked chemically using a reversible cross-
linker such as those of the N-hydroxysuccinimide class of crosslinkers to preserve 
these interactions. An antibody will be used to pull down one of the proteins before 
the crosslinking is reversed. A Western Blot analysis will be performed to detect 
each protein in the elution fraction. If each pulldown shows both proteins are 
coming down when one of them is the target, I will conclude they are interactors. 
In the case of proteins with known functions, verification of these interactions could 
provide important mechanistic insight into how GRA41 performs its functions. For 
proteins whose function is not currently not known, this approach could help to 
identify other novel PV proteins with similar roles to GRA41. These would then be 
genetically disrupted to see if they share similar phenotypes to the knockout of 
GRA41 or if they perform altogether different functions. In addition to investigating 
the proteins found in this list, I also propose to look specifically at GRA22, since it 
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has been shown previously to have a premature egress phenotype, by generating 
a single knockout of GRA22 and a double knockout of GRA41 and GRA22 for 
phenotypic analysis. 
Are there differences between the Type I and Type II GRA41 proteins that could 
provide insight into protein function or parasite biology? 
As I have already shown, though both the Type I and Type II GRA41 
proteins are secreted proteins, they demonstrate an important difference in 
electrophoretic mobility. The Type I GRA41 protein runs as a doublet on an SDS-
PAGE gel while the Type II protein runs as a single band. Further investigation 
reveals that there are six amino acid changes between the two protein sequences 
which could be responsible for the differences observed if any of them are shown 
to be post-translationally modified within the Type I strain. The Type I and Type II 
strains differ greatly in the in vivo virulence and polymorphisms within dense 
granule and rhoptry proteins have been previously shown to be important 
mediators of these virulence differences. I propose to test if the polymorphisms 
between the Type I and Type II strains are important to GRA41 function by 
conducting complementation studies in the knockout strains to determine whether 
or not the Type II protein is capable of rescuing the Type I knockout’s phenotypes 
and vice versa. A failure of the Type II protein to rescue the Type I knockout’s 
phenotypes could help to narrow down key residues associated with certain 
residues and areas of the protein. The specific residues that differ between the two 
strains could be mutated to determine which, if any, impact the rescue of 
phenotype. There are also additional phenotypes of the Type I knockout that have 
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not yet been assessed in the Type II knockout. Verifying whether or not the Type 
II knockout retains the premature egress, TVN disruption and calcium uptake 
phenotypes of the Type II knockout could prove very informative in identifying key 
residues/domains involved in these various phenotypes. 
The exact localization of the Type II protein remains unclear. Though it has 
been shown to be secreted into the parasitophorous vacuole and localizes to the 
tissue cyst wall, it is unclear if it localizes to the TVN of the vacuole or if it is found 
free in the lumen of the PV. Preliminary studies to determine if the Type II GRA41 
protein exists as a soluble or membrane-associated protein should first be 
conducted. As expected for a TVN-associated protein, Type I GRA41 is found 
within the membrane-associated fraction following partitioning with TX-114. If the 
Type II protein does not have the same pattern, this may suggest that it has a 
different localization within the vacuole than the Type I protein, which can be 
verified by immunoelectron microscopy as was done for the Type I protein. 
Additionally, very little is known about the TVN in cysts; if GRA41 continues to 
localize to the TVN of Type II parasites, immunoelectron microscopy of bradyzoite 
cysts expressing a tagged GRA41 could be informative in studying the TVN of 
cysts. 
Does the knockout of GRA41 in a Type II strain lead to a defect in bradyzoite 
cyst maintenance? 
Our preliminary data supports a hypothesis that the loss of GRA41 in a Type 
II strain leads to a defect in the maintenance of bradyzoite cysts, both in vitro and 
in vivo. However, there is much additional work to be done to test this hypothesis. 
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Most importantly, the generation of a complemented strain or an independently-
derived knockout is necessary to verify that the associated phenotypes are directly 
due to the loss of GRA41. Preliminary attempts to generate such a strain resulted 
in a population with a very low rate of successful incorporation and expression of 
the complementation plasmid within the transfected population (<1%) and an 
inability to isolate a positive clone. This was also seen when generating the Type 
II knockout strain, and in this case, the addition of a GFP marker outside of the 
homology arms that allow for incorporation into the target locus helped to eliminate 
clones that had integrated the knockout plasmid randomly. Hundreds of clones 
could be rapidly screened by live fluorescence imaging, rather than the methodical 
screening of dozens of clones that is done by traditional immunofluorescence 
analysis. Since the complementation construct has also been targeted to the 
endogenous locus encoding GRA41, a similar approach could be used to quickly 
screen for parasites that incorporated the plasmid in the correct location.  
Additional work will also aim to further refine and characterize the 
phenotypes associated with loss of GRA41 in a Type II strain. Given the observed 
differences in sequence and electrophoretic mobility (and likely post-translational 
modification), it is important to ask whether or not all of the phenotypes observed 
in the Type I knockout are also found in the Type II knockout. In addition to this, 
looking at bradyzoite formation both with a complemented strain and at additional, 
later time points, will help to further clarify the role of GRA41 in cyst maintenance. 
Based on the pilot in vivo study, future efforts to look at the impact of GRA41 on 
cyst burden are warranted. Since I suspect that GRA41 might play a role in cyst 
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maintenance in vivo as well, additional time points harvested later during chronic 
infection can help elucidate how the infection is progressing over time. Additionally, 
none of the doses utilized in the pilot study led directly to any mouse death during 
the acute infection, so a trial of a higher dose of parasites will be used to determine 
if GRA41 plays a role in virulence in the mouse model. 
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